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Abstract 
Environmental reservoirs of disease can harbour opportunistic pathogens that 
are harmful to human health. Anthropogenic effects such as climate change and 
antimicrobial resistance are likely to cause increase exposure to, and harm from, 
these pathogens. It is thus vital to study these environmental reservoirs in order 
to be prepared appropriately and prevent these diseases from emerging or re-
emerging. Studies into the prevalence and diversity of opportunistic pathogens in 
the environment are largely focused on water sources. Microbial communities in 
soil are known to harbour a diverse range of species, yet are relatively poorly 
understood. Studies typically screen for specific ‘indicator pathogens’, or test the 
virulence of individual pathogens. These methods overlook a great deal of 
pathogenic species that can be present. Recent advances in the Galleria 
mellonella model system have shown that it can be used to screen for pathogens 
in microbial communities taken from environmental samples. We used the G. 
mellonella model to screen for potentially harmful pathogens in soil microbial 
communities. We frequently detected high levels of virulence, suggesting that soil 
often harbours pathogenic species. We were subsequently able to isolate 
pathogens from these soils and characterise their virulence, finding most of them 
to be highly virulent. 16s sequencing determined that the majority of pathogens 
found were either Serratia liquefaciens or Providencia alcalifaciens, both of which 
are known human pathogens. A highly virulent Aeromonas hydrophila was also 
identified. AMR profiling of these isolates found lower levels of antibiotic 
resistance than has typically been reported from clinical isolates. This study 
emphasises the importance of soil as a reservoir for pathogens, and provides a 
glimpse at the range of potentially harmful species that it contains.  
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Introduction  
 
Infectious diseases have been a constant threat to human health throughout 
history (Balloux and van Dorp, 2017). These diseases are caused by the growth 
and replication of microorganisms within the body of a host organism, and are 
usually either bacterial, fungal or viral in nature (Jones et al., 2008). These 
organisms proliferating inside a host can lead to a huge variety of problems as 
they compete with host cells, produce toxic compounds, physically and 
chemically interfere with bodily functions, or directly destroy host cells (Wilson, 
2002; van Baarlen et al., 2007). In this introduction, I provide a brief introduction 
into what pathogens are, the differences between obligate and opportunistic 
pathogens, and give details on some notable infectious diseases, both historical 
and currently emerging. I discuss the effects that anthropogenic changes are 
having on infectious diseases, and highlight why it is increasingly important to 
study environmental reservoirs of disease. Finally I talk about the traditional 
methods for studying these environments, and how new model systems and 
techniques can improve upon them. 
What is a pathogen? 
Pathogens, informally known as germs, are defined as any microorganism that 
has the potential to cause disease (Smilack, 1976). Usually, these 
microorganisms are either simple cellular life such as bacteria or fungi, or mobile 
genetic elements such as viruses (Jones et al., 2008). If these pathogenic 
microorganisms are able to enter the internal systems of another organism, they 
have the potential to cause great harm to it. Organisms that are colonised by such 
pathogens are known as hosts, and the potential harm that the pathogen can 
cause is known as virulence (Bull, 1994). Virulence is affected by the range of 
‘virulence factors’ that the pathogen can produce, which include many toxic 
chemicals, destructive enzymes, and compounds which help the pathogen evade 
or damage their host’s immune system (Chen, 2004). To defend against 
pathogens, host organisms have immune systems, which include a wide range 
of physical, chemical, and molecular defences (Medzhitov and Janeway, 2000).  
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The problem of opportunistic pathogens 
Some pathogenic organisms are ‘obligate pathogens’, which means that at some 
point in their life-cycle they need to infect a host organism to survive and 
proliferate (Balloux and van Dorp, 2017). Examples of this include viruses, all of 
which are obligate pathogens due to their need to use a host cell for replication, 
along with the pathogens responsible for diseases such as tuberculosis and 
leprosy (Jagielski et al., 2016). However, many pathogenic species are in fact 
‘free-living’ organisms, perfectly capable of surviving without the need for a host 
organism. These facultative or ‘opportunistic’ pathogens typically only cause 
virulence in hosts with weakened immune systems (Balloux and van Dorp, 2017). 
An example of this is the bacterium Staphylococcus aureus, which is commonly 
present on human skin. Normally this bacterium is a commensal, meaning it can 
survive on our skin with no ill effect to us. However, if the skin is breached S. 
aureus can enter the body, where it has the potential to cause serious skin and 
wound infections, bacteremia and toxic shock syndrome (see Table 1) (Tong et 
al., 2015). As well exploiting as physical breaches to a host’s immune system, 
opportunistic pathogens can be particularly dangerous to hosts with reduced 
internal immune function, a state known as immunodeficiency or 
immunosuppression (Smith, 1973). This state can be caused by a variety of 
factors including long-term conditions such as HIV infection (Fauci, 1988), 
genetic predisposition (Buckley et al., 1997), or the onset of old age (Saltzman 
and Peterson, 1987). It can also be affected by factors such as malnutrition 
(Bourke, Berkley and Prendergast, 2016), or be deliberately induced for certain 
medical procedures such as organ transplantation (Borel, 1998). Because of the 
free-living nature of opportunistic pathogens, there also exist a great number of 
environmental populations of them, which can act as reservoirs of disease 
(Gerba, 2015). This complicates efforts to manage the disease, as infections can 
arise without host-to-host transmission. Therefore it is necessary to maintain a 
good understanding of what pathogens are present in the environment, and I will 
discuss this issue in more detail later in this introduction. 
Notable examples of bacterial diseases 
Pathogens by nature encompass an extremely diverse range of organisms, 
however the vast majority of infectious human diseases are caused by species 
of bacteria (Jones et al., 2008), and it is these which we will focus upon. Here I 
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briefly describe some examples of notable bacterial diseases that pose a 
significant threat to human health. 
One of the most infamous pandemics in human history is the bubonic plague, 
also known as ‘The Black Death’ or simply ‘The Plague’. This disease ravaged 
Europe in the 1300’s, causing an enormous loss of life, estimated to be 20-60% 
depending on the country (Cook, 2004). The bacterium responsible, Yersinia 
pestis, is believed to have been carried by rats, and causes large pustules and 
buboes to form on infected humans, which can spread the disease further (Perry 
and Fetherston, 1997). It is confirmed to be responsible for other devastating 
outbreaks across history, including the Plague of Justinian which contributed to 
the fall of the Roman Empire (Wagner et al., 2014). Fortunately, it is rare for a 
pathogen to exhibit the levels of virulence and infectivity that The Plague reached, 
and thanks to the development of modern medicine, bacterial infections can now 
usually be treated quickly with antibiotics (Perry and Fetherston, 1997). Plague 
infections in humans are now rare, although not unheard of, as the bacterium still 
persists in some wild mammal populations (Perry and Fetherston, 1997) 
An example of a less-virulent, but still dangerous bacterial disease is 
Salmonellosis, often known as food poisoning or gastroenteritis. Salmonellosis is 
caused by bacteria of the Salmonella genus, which can persist for weeks in the 
intestines of animals including humans (Crum-Cianflone, 2008). Disease most 
commonly arises when fecally-contaminated food is consumed without being 
correctly prepared; undercooked meat and eggs in particular are common 
examples (Crum-Cianflone, 2008). Salmonella infection can be asymptomatic, or 
it can cause severe abdominal cramps, diarrhoea and dehydration, and if 
complications arise, even mortality (Acheson and Hohmann, 2001). However, 
Salmonella infections can be easily avoided with proper hygiene and sterilisation 
of foodstuffs. 
Cholera, caused by the bacterium Vibrio cholerae, provides a strong example of 
the threat that can be posed by environmentally-sourced bacteria. Cholera is 
most commonly contracted by drinking water contaminated with human faeces, 
and can cause severe vomiting and diarrhoea, leading to extreme dehydration 
and even death (WHO, 2019). The bacterium can be removed from water sources 
by adequately sterilising them before consumption, and as such the disease is 
very rare in developed countries but is still a serious threat in developing regions 
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(Griffith, Kelly-Hope and Miller, 2006; Ali et al., 2012). Infections are suspected 
to be underreported due to the negative connotations an outbreak will have, but 
studies attempting to correct for this estimate 2.9 million cases and 95,000 deaths 
per year occur in endemic countries (Ali et al., 2015). Historically cholera is very 
important to the study of spatial epidemiology, as John Snow’s work during the 
1854 outbreak in London was instrumental in stopping the spread of the disease 
(Shiode et al., 2015). 
Emerging infectious diseases 
While the examples of bacterial diseases mentioned above pose significant 
health risks to humans, they are reasonably well-understood and can generally 
be easily avoided or treated.  However, there are many diseases that are 
currently more difficult to deal with, and reported incidences of some of these are 
on the rise. These ‘emerging infectious diseases’ (EIDs) are defined as “those 
whose incidence in humans has increased within the past two decades or 
threatens to increase in the near future” (van Doorn, 2014). This may be due to 
either novel or previously undetected infections. There are also cases of known 
infections currently increasing in frequency, defined as re-emerging diseases 
(National Institutes of Health, 2007). In recent years a worrying number of 
diseases are re-emerging due to the phenomenon known as antimicrobial 
resistance, which will be discussed later in this chapter. Urbanised areas are 
particularly likely to be hotspots for EIDs due to the density and frequency of 
contact of populations within them (Neiderud, 2015). This year to date (at the time 
of writing, 2019) the World Health Organisation has reported many significant 
disease outbreaks  including Cholera, Listeriosis, Gonorrhoea, Carbapenem-
resistant Pseudomonas aeruginosa, and numerous viral infections (WHO, 2019).  
The influence of anthropogenic effects on EIDs  
Anthropogenic changes often have a large part to play in disease emergence and 
re-emergence. Many outbreaks of disease have been caused by the human 
introduction of infectious agents to susceptible populations, a prominent historical 
example being the movement of boats bearing Plague carriers (Tognotti, 2013). 
It is thus important to remain aware of potential ways that humans could affect 
disease dynamics in the future, and I will describe some of these here. 
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One of the most pressing and wide-scale examples of this is climate change 
(Khasnis and Nettleman, 2005; Cavicchioli et al., 2019). Global temperature shifts 
are predicted to have a huge effect on both hosts and pathogens for a variety of 
reasons (Wu et al., 2016). For example, many  microorganisms (particularly 
bacteria) will be capable of utilising warmer temperatures to directly speed up 
their generation time, although this will not necessarily favour pathogenic 
species, and temperatures could even become hot enough to inhibit growth (Wu 
et al., 2016). Host species will also be affected significantly, as changing 
temperatures significantly increase to the strain on their immune systems, making 
it easier for infectious agents to gain a foothold in the body (Raffel et al., 2006). 
Vector populations will also be affected; there is evidence of increasing 
populations of mosquitoes in recent years (Watts et al., 2018). There will be many 
environmental effects of climate change, for example the destruction of many 
ecosystems threatens to shift the species ranges of both hosts and pathogens. 
This will increase the likelihood that susceptible host species become exposed to 
novel diseases, while also granting novel pathogens new opportunities to spread 
(Sorci, Cornet and Faivre, 2013). Such incidents are already beginning to occur, 
such as a recent outbreak of Anthrax in Russia, thought to have been started by 
an infected carcass becoming exposed from permafrost due to a heatwave 
(www.bbc.co.uk/news/world-europe-36951542). 
Another prominent factor is the ever increasing human population. By itself this 
creates more potential hosts living in close proximity to one-another, especially 
in growing cities, where the density and proximity of hosts increase the chance 
of epidemic or pandemic EIDs developing (Neiderud, 2015). Population growth 
also leads to increasing globalization and urbanization, which creates further 
problems. For example modern transportation is expediting the spread of 
disease, as our increasingly interconnected world allows pathogens to move from 
one area to another very quickly. Air travel appears to be one of the main vectors 
of this type of spread (Colizza et al., 2006). Not only does this increase the rate 
at which they can spread, but it also allows for pathogens to reach hosts that 
have little-to-no immunity to them, potentially causing widespread epidemics. 
Malaria has already been noted to have been ‘imported’ to various countries on 
a number of occasion due to the travel of infected individuals, as has Yellow 
Fever, Dengue and West Nile Virus (Tatem, Rogers and Hay, 2006).  
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The ability of modern medicine to keep diseases in check has also been 
undermined in recent years. This is in part due to ‘vaccine hesitancy’, the distrust 
of established medical procedures partly thanks to misinformation spread by 
discredited scientists (Wakefield et al., 1998). This has unfortunately led to many 
easily avoidable infections occurring, and has recently been implicated in the 
current return of measles in the UK, causing the loss of its W.H.O. status as an 
eliminated disease in the country (www.gov.uk/government/publications/ 
measles-confirmed-cases). 
The rise of antimicrobial resistance 
Another major anthropogenic factor allowing for the re-emergence of diseases is 
the spread of antimicrobial resistance (AMR); the evolution of so-called 
‘superbugs’. This phenomenon is the result of microorganisms evolving to 
become less susceptible to compounds that are used to treat infections (WHO, 
2020). This is a major problem in modern-day healthcare, and it is predicted that 
by 2050 AMR infections will be the most common cause of death world-wide 
(Figure 1, O’Neill, 2016). The most well-known example of AMR is bacterial 
pathogens becoming antibiotic-resistant, becoming much harder to treat through 
clinical means. Most antimicrobial compounds are produced naturally by 
environmental microorganisms, and those that produce them or are regularly 
exposed to them usually have some innate resistance to them (Martinez, 2008). 
Others are naturally susceptible, but can acquire genes coding for resistance 
through a number of means. The most common method for this is horizontal gene 
transfer, which is the process of acquiring genetic information from the 
surrounding environment or unrelated bacterial species (Thomas and Nielsen, 
2005). Bacteria regularly do this through a process known as conjugation, 
whereby the bacteria link to one another using a ‘pilus’ and exchange genetic 
information in the form of plasmids, a type of mobile genetic element (Llosa et al., 
2002). Alternatively, genetic information may be transferred by transduction; 
where mobile genetic elements such as bacteriophages incorporate genes from 
their host and transfer them between cells (Ochman, Lawrence and Groisman, 
2000). Some bacteria are also capable of acquiring genes from the environment 
around them through a process known as bacterial transformation, which can 
allow them to acquire and use genes from dead cells, even of another species 
(Riffith, 1928). Alternatively, it is also possible for random genetic mutations to 
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cause new mechanisms of antimicrobial resistance, although the exact rates at 
which this can happen are subject to a complex array of factors (Martinez and 
Baquero, 2000).  
 
Figure 1: Predicted deaths due to AMR. The Review on Antimicrobial 
Resistance predicts that deaths due to AMR will exceed all other causes of 
mortality by 2050 (O’Neill, 2016). 
 
Once a resistance gene is present in a pathogen it is subject to the rules of natural 
selection. The chance for a resistant phenotype to emerge is limited by any 
fitness costs that the change incurs, and as such resistant strains will often be 
outcompeted by the wild-type (unmodified) strains (Martinez and Baquero, 2000). 
The costs incurred partly depend on the location of the mutation in the genome, 
and can often be significantly lower if the gene is located on a plasmid (Vogwill 
and MacLean, 2015) - a type of mobile-genetic-element - or if secondary 
mutations increase fitness without affecting the resistance gene (Melnyk, Wong 
and Kassen, 2015). However, the selection pressures change when in the 
presence of antimicrobials, where resistant strains will have a fitness advantage 
and encourage the proliferation of the resistance gene (Skalet et al., 2010).  
In recent years we have become increasingly reliant on antibiotics in both 
healthcare situations and in farming practices, particularly in the developed world. 
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While use of these amazing compounds has led to a ‘golden age’ where most 
diseases pose little threat, this could easily change. Because of the widespread 
prevalence of antimicrobials in so many environments, these is now huge 
selection pressure on pathogens to become resistant (WHO, 2020). This was 
most publicised during the rise of methicillin-resistant Staphylococcus aureus 
(MRSA) infections in hospitals from its initial discovery in 1968 to the rise of 
‘epidemic MRSA’ in the 1980’s and early 1990’s (Duerden et al., 2015), causing 
a huge public health risk. This kind of resistance is becoming increasingly 
common in pathogenic species, and is a trend that is likely to only get worse. 
Indeed, many dangerous diseases such as tuberculosis are now displaying 
simultaneous resistance to more than one antibiotic, leaving few options for 
treatment available (Millard, Ugarte-Gil and Moore, 2015). Strains of 
Vancomycin-resistant Enterococci, which are resistant to even antibiotics of last 
resort, are becoming increasingly common too (McGuinness, Malachowa and 
DeLeo, 2017).  
Which environments are typically disease reservoirs? 
It is important to maintain awareness of the spread of disease-causing organisms, 
such that we are able to adequately prepare countermeasures for them if 
infections arise. This is especially difficult for opportunistic pathogens because 
unlike obligate pathogens they can exist in natural environments in the absence 
of host species (Balloux and van Dorp, 2017). Therefore there exist persistent 
environmental sources aka ‘reservoirs’ of opportunistic pathogens with the 
potential to become infectious (Berg, Eberl and Hartmann, 2005; Gerba, 2015). 
This makes it important to perform surveillance of environments which could be 
potential disease reservoirs. Pathogens in general are capable of surviving in a 
wide range of reservoirs, which can include host populations of humans and 
animals (Haydon et al., 2002), and in man-made environments such as hospitals 
(Dancer, 2011), and even on the surfaces of mobile phones (Brady et al., 2009). 
These are all important areas for research into disease transmission. However, 
for the purposes of this study I will be focusing on external, environmental 
reservoirs. 
Water sources are one of the most vital areas in which to maintain environmental 
surveillance, as many pathogenic species are able to survive and even thrive in 
water (Ramírez-Castillo et al., 2015). Some level of exposure to waterborne 
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pathogens is unavoidable, particularly in water sources which are used for 
bathing or drinking. If correctly treated most pathogenic species can be removed 
from water before humans are exposed to it (LeChevallier, 2013). However this 
is not always done, and unhygienic or poorly sanitised water is thought to 
contribute to 3.2% of deaths globally (WHO, 2010). Water is known to transmit a 
wide variety of dangerous diseases, some of which include cholera, typhoid and 
dysentery (Cabral, 2010). Pathogenic species such as Salmonella, Escherichia 
coli, Legionella pneumophila, and Pseudomonas aeruginosa have also been 
found in drinking water (Falkinham, Pruden and Edwards, 2015). Studies also 
show that microplastics in water are providing novel substrates for pathogens to 
grow on (Keswani et al., 2016), potentially compounding the issue. 
It is also possible for the air to transmit pathogenic species. Airborne pathogens 
can spread quickly and cause widespread outbreaks, as seen with severe acute 
respiratory syndrome (SARS) in Asia (Gumel et al., 2004), or seasonal influenza 
strains, which are estimated to cause 3-5 million severe illnesses and 290-650 
thousand deaths annually (WHO, 2018). Studies have shown that the microbial 
species present in the air are affected by seasonal variation; for example in the 
U.S. Pseudomonas, Burkholderia, Rhizobiales, and Sphingomonadales are 
found in the summer, while Bacteroidales, Clostridiales, and Fusobacteria are 
more common in winter (Bowers et al., 2011). Air pollution itself can be hazardous 
to health, and so there are many studies into its effects, however in general the 
majority of microorganisms found in polluted air are non-pathogenic (Cao et al., 
2014).  
However, one natural environment in particular has received relatively little 
attention with regards to the pathogens it contains: soil. Soil environments can be 
a persistent source of diseases and need to be studied and understood (Berg, 
Eberl and Hartmann, 2005). Soil pathogens have the potential to infect the food 
that we eat as well as spreading directly into humans (Baumgardner, 2012). 
Natural microbial communities can contain billions of cells and thousands of 
species in every gram of soil matrix (Pursey et al., 2018), and due to the nutrient-
rich nature of soil it is probable that it is home to many pathogenic microbes that 
have as yet gone undiscovered. While some studies have been done into the 
pathogens that can be present in the roots of food crops, relatively little is known 
about the species and virulence of opportunistic pathogens in soils in general. As 
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the primary focus of our study, soil microorganisms will be discussed in more 
detail in chapter 2. 
Traditional methods for detecting environmental pathogens 
To detect pathogens in environmental reservoirs a number of screening methods 
have been developed. Here I will briefly describe a few of them, their merits and 
drawbacks.  
The detection and quantification of specific bacteria which typically reside in 
human and animal gastrointestinal tracts is often used as a proxy for water quality 
(Anderson, Whitlock and Harwood, 2005; Cabral, 2010; de Brauwere, Ouattara 
and Servais, 2014). These ‘faecal indicator bacteria’ (FIB) such as Escherichia 
coli are usually filtered from the water sample by passing it through a filter 
membrane, then cultured on nutrient broth (Quilliam et al., 2011). This method 
can also be used for sediment samples, but they must first be thoroughly mixed 
with a sterile buffer solution, then the supernatant can be processed in a similar 
way to water samples (Anderson, Whitlock and Harwood, 2005). Following a 
period of incubation, growing microbial colonies can be visibly detected. Colonies 
can then be investigated further to determine their identity, using variables such 
as colony size and colour, or microscopy (Váradi et al., 2017). If looking for a 
particular species such as E. coli then a specific nutrient agar can be used to 
select for it, which may also contain chemical ‘inhibitors’, typically antibiotics, 
which exclude or at least slow the growth of any other species (Lagier et al., 
2015). FIB by themselves are unlikely to cause particularly serious diseases, but 
detecting and quantifying their numbers can infer the presence of other, more 
dangerous faecal pathogens (Schriewer et al., 2015), along with providing an 
estimate of how sanitary the sample is. This detection method is quick and 
simple, requiring relatively little complex equipment. 
Another prominent environmental screening technique is the use of molecular 
biology to determine which species are present in a sample by detecting specific 
genetic markers of interest (Quilliam et al., 2011). This method is often used in 
combination with an initial stage of pathogen culture prior to DNA extraction, 
although some kits allow for direct extraction of nucleic acid from environmental 
samples (Tsai and Olson, 1991; Quilliam et al., 2011). Polymerase chain reaction 
(PCR) is then used to amplify regions of nucleic acid using primers for a specific 
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gene, usually one that is highly conserved (Fincher, Parker and Chauret, 2009). 
Once amplified, nucleic acid can be detected through a number of means. 
Qualitative PCR simply determines the presence or absence of specific genes 
via gel electrophoresis, in which nucleic acids present can be visually 
differentiated (Lee et al., 2012). There is also quantitative PCR (qPCR) aka real-
time PCR, which can determine the relative frequency of a specific gene within a 
sample by detecting a fluorescent marker and comparing the fluorescence to a 
control (Ponchel et al., 2003). PCR-based methods can detect a wider range of 
pathogens with a higher degree of accuracy than FIB methods, including those 
that would be unculturable in the lab  (Cai, Caswell and Prescott, 2014), but is 
significantly more time-consuming and resource-intensive. 
Metagenomics approaches can also be used to detect a relatively wide range of 
environmental pathogens. This involves the extraction of all DNA from an 
environmental sample (the metagenome), and transplanting fragments of this 
DNA into clonal vectors such as plasmids, which can then be used as a ‘DNA 
library’ (Daniel, 2005). These DNA libraries can then be screened for specific 
nucleotide sequences or metabolic activity. One way of doing this is via detecting 
specific ‘genetic fingerprints’ (Maron et al., 2005). During sequence analysis, 
microsatellites – specific conserved sequences of DNA that repeat themselves – 
can be used as a marker to detect the presence of a particular pathogen which 
is known to contain that genetic sequence (Ellegren, 2004). Microsatellite arrays 
can be used to screen for the presence of many pathogens at once (Wang et al., 
2002; McLoughlin, 2011), and can be used to detect specific resistance or 
virulence genes. They can even detect DNA markers without the need for PCR 
(Call, Borucki and Loge, 2003).  
Limitations of traditional detection techniques 
While the practises of detecting ‘indicator pathogens’ and specific gene 
sequences are certainly useful in providing some indication of how pristine a 
sample is, there are also inherent drawbacks to these approaches. For example, 
the process of DNA extraction itself can damage and degrade sequences, 
showing false negatives (Van Burik et al., 1998). It can also release chemicals 
from the samples that interfere with the PCR process (Lu et al., 2015). In the case 
of fungal pathogens, PCR based methods cannot distinguish between active and 
dormant species, though there are alternative methods such as fluorescence in 
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situ hybridisation (FISH) that can (Tsui et al., 2011). For metagenomics-based 
approaches, considerable time and money needs to be invested in creating and 
maintaining DNA libraries, and researching and developing suitable detection 
probes, although these costs are steadily decreasing (Kunin et al., 2008; Teeling 
and Glockner, 2012). As well as the possibility of false negatives, genetic 
methods can also provide false positives. Some of the species and genes 
detected in this way can in fact be apathogenic, since it is not possible to directly 
assess the virulence of any species detected, only look for virulence genes 
(Thoerner et al., 2003). However, the biggest problem with all of these traditional 
techniques is that they are reliant on detecting very specific elements within a 
sample, be it indicator pathogens or genetic sequences. This limits all of these 
methods to detection of a subset of known elements and renders them ineffective 
at detecting novel pathogens. Therefore these studies only provide a small 
snapshot of the potential pathogenic load of each sample; the total pathogen load 
could be much greater.   
The Galleria mellonella model system 
Another important approach in the study of pathogens is the inoculation of model 
organisms with specific pathogen isolates to directly assess their virulence. This 
method uses organisms that share a similar immune response to humans, and 
are easily bred and contained. Mouse or zebrafish models are typically used (e.g.: 
Barman et al., 2008; Bergeron et al., 2017), however there are significant 
financial, ethical and logistical limitations to such studies (Tsai, Loh and Proft, 
2016). Due to the number of experimental replicates required to accurately 
assess virulence, large populations of model organisms are required. Sufficient 
numbers of the model organism must also be obtained on a regular basis, either 
through reproduction or purchase from an external supplier. Another model 
organism which studies have begun to use as a more easily manageable, 
ethically sound, and cheaper substitute for mammalian infection studies is the 
larvae of the wax moth Galleria mellonella (Champion, Wagley and Titball, 2016).  
G. mellonella larvae have been shown to have a surprisingly similar innate 
immune system to mammals (Ramarao, Nielsen-Leroux and Lereclus, 2012). 
Many components of the innate immune system are highly conserved between 
mammals and insects, with some of the mechanisms involved being ancient in 
origin (Vilmos, 1998; Hoffmann, 1999). In immune responses, cells’ external 
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membranes provide a first line of defence against invading elements, with 
peptides and antimicrobial agents present on these surfaces (Alberts et al., 
2017). In both insects’ cuticles and mammals’ epidermis the main structural 
component is protein, and pathogens either take advantage of physical breaches 
or create their own using proteinases, the latter method being more common in 
insects than mammals (Scully and Bidochka, 2006). Intracellular pathogens then 
use a range of virulence factors to breach cell membranes, disable host defence 
molecules and acquire resources. There are strong similarities in the 
mechanisms used between insect and mammalian pathogens, with it being 
common in both cases for proteases to be utilised (Leger, Charnley and Cooper, 
1987; Cowell et al., 2003). Bacterial toxins seek to exploit similar targets across 
both mammalian and insect hosts. For example, both the insect midgut and 
mammalian intestine microvillar surfaces have glycoconjugate receptors which 
are bound by toxins from both insect and mammal pathogens, typically Cry toxins 
and Ctx toxins respectively (Cuatrecasas, 1973; Jurat-Fuentes, Gould and 
Adang, 2002).  
Both insects and mammals have innate immune systems, which work to disrupt 
and destroy any pathogens which make it inside the host organism. While there 
are differences in the mechanism of action of some of these components, the 
basic principles remain the same across both host types. Both produce anti-
microbial substances to inhibit and damage invading cells (Vilmos, 1998). Both 
also produce phagocyte cells which consume and destroy invaders, in the case 
of insects these are known as haemocytes, which are analogous to mammalian 
neutrophils (Bergin et al., 2005). Both types of phagocyte have similar 
mechanisms of action: they bind to the invading cell, envelop it and destroy it with 
chemicals and protein complexes (Scully and Bidochka, 2006). In both insects 
and mammals, the immune system detects highly conserved microbial 
components to recognise pathogens. These ‘pathogen-associated molecular 
patterns’ (PAMPs) are detected by pattern recognition receptors (PRRs) which 
trigger an immune response.  Insect and mammal PRRs have been shown to 
have a number of similarities (Khush and Lemaitre, 2000; Kimbrell and Beutler, 
2001). Pathogens of both host types have also evolved similar methods of 
immune evasion by changing the PAMPs present on their surface (Scully and 
Bidochka, 2006).  
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The most important factor when determining whether a model organism is 
suitable as a proxy for mammalian infection studies is whether there is a 
comparable mortality rate for both host organisms. Studies have shown that this 
indeed appears to be the case for Galleria; there are strong correlations in 
mortality rates between G. mellonella and mice when injected with infectious 
agents such as Pseudomonas aeruginosa, Listeria and Candida albicans 
(Jander, Rahme and Ausubel, 2000; Brennan et al., 2002; Mukherjee et al., 
2010). Indeed, there is evidence to suggest that bioassays using Galleria are also 
able to identify virulence factors that are involved in mammalian pathogenesis 
(Jander, Rahme and Ausubel, 2000).  
While the aforementioned similarities between the G. mellonella model and 
traditional mammalian models show that it is a viable alternative, Galleria have 
also been shown to have a number of significant advantages over traditional 
models. Galleria reproduce relatively quickly, allowing for large sample sizes to 
be studied at once, improving the accuracy and consistency of studies (Tsai, Loh 
and Proft, 2016). Galleria are also much easier to contain than mammalian model 
organisms, requiring no large-scale facility to house them, and can be kept at 
temperatures as low as 15°C without ill effect (Ramarao, Nielsen-Leroux and 
Lereclus, 2012). Another major advantage is that as they are an invertebrate 
model, studies involving Galleria require no ethical approval (Tsai, Loh and Proft, 
2016). This makes studies more expedient, and allows for high-throughput 
studies that would be ethically questionable in mammalian models. Additionally, 
the usage of Galleria as a replacement for mammalian models contributes to a 
reduction in mammalian suffering (Scully and Bidochka, 2006), and as such is 
being promoted by the National Centre for the Replacement, Refinement & 
Reduction of Animals in Research (NC3RS.org.uk), among others.  
Typical use of the Galleria model is to infect larvae with a predetermined volume 
of a specific strain of pathogen through either intrahemocoelic injection or force-
feeding (Ramarao, Nielsen-Leroux and Lereclus, 2012). Larvae can then be 
incubated at 37°C (human internal body temperature) with no adverse effects, 
allowing for studies on human pathogens. Following incubation, the survival rates 
of Galleria are measured, and mortality can be easily judged due to the strong 
degree of melanisation exhibited upon death (Ramarao, Nielsen-Leroux and 
Lereclus, 2012). While it is true that Galleria lack the adaptive immune system 
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present in vertebrates, this immune system has evolved to protect against repeat 
infections by the same pathogen. The innate immune system is the primary 
defence against novel pathogens, and thus studies using insect models are still 
relevant when carrying out experiments such as mortality assays for novel 
pathogens.  
Using the Galleria model to detect environmental pathogens 
Studies are now beginning to develop the Galleria model system even further. 
Hernandez et al. (2019) recently showed that it is possible to use G. mellonella 
larvae as a bioindicator for microbial water and sediment quality by inoculating 
G. mellonella with both water sample extracts and soil washes containing entire 
microbial communities. The presence or absence of pathogens within these 
microbiomes was easily detectable via a simple assay of Galleria mortality. A 
number of pathogenic microbial communities were detected in this way. 
Subsequently, virulent pathogens from those communities were selectively 
enriched, isolated and studied further. This type of virulence assay has the 
significant advantage over traditional screening techniques in that it can directly 
screen for virulence from environmental pathogens without any prior knowledge 
of what pathogen species are present, and without the need to detect any specific  
genetic elements within it; allowing for the detection of novel pathogens that 
would otherwise go undetected. Indeed Hernandez et al. found a strain of Proteus 
mirabilis which carried genes from Salmonella, and a species of Vibrio injenensis 
that had never been detected outside of Korea before.  
In this study, my collaborators and I used the G. mellonella model system in a 
manner similar to Hernandez et al.; using a whole-community inoculation 
approach to detect and study pathogens within the understudied environmental 
reservoir of soil.  
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Chapter 2     Bacterial pathogens in soil 
Pathogens in soil 
Soil is an environmental reservoir of disease in which studies are severely 
lacking. It is well-known to be a nutrient-rich environment teeming with bacteria 
and other microorganisms. For example a single gram of forest soil has been 
estimated to contain 4x107 prokaryotic cells, and a single gram of cultivated soil 
and grasslands to contain 2x109 prokaryotic cells (Daniel, 2005). These 
microorganisms are also extremely diverse, due to the extremely heterogeneous 
nature of soil (Fierer and Jackson, 2006). The solid components of soil can vary 
widely in their composition, from the materials they are comprised of (such as 
sand, silt, clay, and organic matter) to the particle size and plants growing in them, 
all of which have a large effect on the microbial diversity (Garbeva, van Veen and 
van Elsas, 2004). Additionally, many soils experience regular fluctuations in 
temperature, water availability and pH, creating greater habitat differentiation 
within those soils and allowing for a huge range of potential niche habitats for 
microbes (Fierer and Jackson, 2006). A large proportion of the species present 
are endemic to the soil, although some are ubiquitous - being found in many other 
environments too. There is evidence to suggest that pathogens can often be 
introduced into soil via the deposition of contaminated fertiliser or animal faeces 
(Park et al., 2012).  
Studies into pathogens in soil microbiomes typically focus on control of plant 
pathogens, particularly those used as crops (Weller et al., 2002; Dordas, 2008; 
Sankaran et al., 2010). While this is certainly an important field of study, and 
essential for food security, there is relatively little knowledge as to which soil 
pathogens could potentially cause a direct threat to human health. For these 
pathogens to have the potential to infect humans they must be capable of growing 
at 37°C (human internal body temperature) and studies suggest that this is quite 
common in soil bacteria (Berg et al, unpublished). Bacteria in general are one of 
the most common types of human pathogen, and in the interest of time it was 
decided that our study focus on these. Some examples of clinically relevant 
bacterial pathogens that are known to be contracted directly from soil include, but 
are not limited to, those in Table 1.  
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Table 1: Examples of clinically relevant soil-borne bacterial pathogens 





leading to seizures. 
Potentially fatal 
Spores known to 
persist in soils for long 





can lead to 
asphyxiation 
Often found in soils, 
infection commonly 
occurs via ingestion of 
contaminated food 
Bacillus cereus2 
Gastroenteritis. Can lead 










Initially flu-like, but 
often causes fatal 
internal damage if 
inhaled or ingested 
Low concentrations 
found in soil, but meat 
from grazing animals 
can contain dangerous 
levels. Notoriously 
used as a bioweapon 
Listeria 
monocytogenes4 
Gastroenteritis. Can lead 
to meningitis, pneumonia 




















pneumonia, UTI’s, sepsis, 
and meningitis 
Various due to the 
range of diseases 
caused 





Skin and wound 
infections, bacteremia, 
food poisoning, toxic 
shock syndrome 





but also present in soil 
Escherichia coli8 
Very commonly 





Infections usually food 
or water borne. Soil 
deposition often from 












water and soil 
Enterobacter 
spp.10 
UTI’s, respiratory tract 
infection, bacteremia, soft 
tissue infections, and 
many others 
Widely varied 
depending on site 
of infection 
Intestinal tracts and 
skin of humans and 
animals, water, soil 
and plants 
Examples of known bacterial pathogens that are found in soil. References as 
follows. 1: (Baker et al., 2009), 2: (Granum and Lund, 2006), 3: (Spencer, 2003), 
4: (Rees, Doyle and Taylor, 2017), 5: (Gellatly and Hancock, 2013), 6: (Li et al., 
2011; Cristina, Sartini and Spagnolo, 2019), 7: (Brandt et al., 1999; Tong et al., 
2015), 8: (Yang et al., 2017), 9: (Eng et al., 2015), 10: (Sanders and Sanders, 
1997; Loiwal et al., 1999). Additional references: (Brandt et al., 1999; 
Baumgardner, 2012; Tong et al., 2015)  
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The significance of rhizosphere bacteria 
Within environmental reservoirs there are hot-spots of microbial activity. In soil it 
appears that the most active area is the layer of soil influenced by root 
metabolism, dubbed the rhizosphere by Hiltner in 1904 (Hartmann, Rothballer 
and Schmid, 2008). Plants create an increase in the turnover of organic nutrients 
around them thanks to both their own physical and chemical processes, and also 
the fact that they draw in other organisms such as herbivores and detrivores 
which also accelerate the process. Thanks to this, the rhizosphere has a high 
concentration of nutrients and microbes competing for them (Garbeva, van Veen 
and van Elsas, 2004). Plants have a complex relationship with soil bacteria, some 
having symbiotic relationships which aid the uptake of soil nutrients and help to 
fixate nitrogen (Frey-Klett, Garbaye and Tarkka, 2007), while other microbes 
serve as plant pathogens or have a neutral effect. This high concentration of 
microbes in the environment causes strong inter- and intra-species selection 
pressures.  Rhizosphere bacteria must adapt to these pressures, and this often 
includes the creation and dispersal of antimicrobial compounds to combat one 
another (Hibbing et al., 2010). There is also a greater chance for horizontal gene 
transfer of resistance genes to occur in such environments due to the high 
concentration of bacteria, aiding the spread of resistance genes. We hypothesise 
that these factors in a diverse and competitive environment such as the 
rhizosphere have the potential to select for virulent, resistant and quick-growing 
pathogens. Due to the sheer diversity of the rhizosphere and lack of studies in 
this area, it is possible that these pathogens have hitherto gone undetected; thus 
soil could potentially harbour dangerous opportunistic human pathogens. 
Aims of this study 
To briefly reiterate, the majority of studies into soil pathogens are interested in 
those that are plant pathogens, particularly those of crops. Those studies that do 
look at human pathogens are generally focused on those that can be transmitted 
to humans from poorly prepared food, particularly those found in the roots of 
crops. There has been relatively little investigation into what pathogenic species 
occur in other types of soil, and this is the knowledge gap that this study 
investigates.  
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Our aims were to: 
 Determine whether virulent human pathogens are present in soil microbial 
communities using G. mellonella assays. 
 Analyse whether soil type and location affect the prevalence of virulent 
microbial communities. 
 Determine which soil pathogens are the most virulent using further G. 
mellonella assays. 
 Identify the microbial species present in pathogenic soils using 16s 
sequencing, paying particular regard to the most virulent isolates. 
 Compare how similar our isolated soil pathogens are to reported human 
infections by those species in terms of antimicrobial resistance and 16s 
sequence.  
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Materials and Methods 
Soil sample collection 
We collected a total of 40 soil samples from locations in Cornwall, UK in 2019 as 
described in Table 2. Sites were chosen at random from easily reachable grassy 
and wooded areas within walking distance of the University of Exeter Campus, 
with the exception of samples from Wheal Jane (‘A’ samples), the general area 
of which was deliberately chosen to obtain metal-contaminated soil samples. 
Exact coordinates, descriptions of each location and maps of each of the 
sampling sites are detailed in Table S1 and Figure S1. At each site, the topsoil 
was removed to a minimum 5cm depth, and a universal tube (30ml, Thermo 
Scientific) was filled completely with the exposed soil using a sterile metal spoon. 
Disposable gloves were worn to avoid contamination of the samples, and both 
gloves and spoon were sterilised with ethanol before and after collecting each 
sample. Collection of rhizosphere soil samples (‘G’ samples) was achieved via 
extraction of a section of turf with soil still attached, which was transported in a 
sterile plastic bag. A second, paired sample was then taken from the exposed 
area in the same manner as previously described. Rhizosphere soil was removed 
from the roots in a Category II extraction hood via shaking and further loosened 
with sterile tools if needed. Two samples taken from river bank soil were collected 
in a similar manner to the initial samples, however no topsoil removal was 
necessary as they were collected directly from the exposed mud of the river 
banks and bed.  
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Wheal Jane, Cornwall, 
UK 
50.231, -5.128 A 7 
Sampling dates and approximate locations from which all 40 environmental soil 
samples were taken. Exact coordinates and maps of each individual sampling 
site can be found in Table S1 and Figure S1. 
 
Extraction of bacterial communities from environmental samples 
All soil samples were brought to the lab for processing on the same day as 
collection, with all further methods being undertaken in a Category II extraction 
hood to avoid contamination. Bacterial extraction methods were based on 
Hernandez et al. (2019). Each soil sample was removed from the universal tube 
and gently mixed with the sterile spoon to homogenise it. 10g of each sample 
was then placed into a fresh universal tube. 10ml of sterile M9 buffer solution 
(12.8 g L-1 Na2HPO4-7H2O; 3 g L-1 KH2PO4; 0.5 g L-1 NaCl; 0.1 g L-1 NH4Cl) 
was added to this, and the mixture vortexed on a Stuart® Vortex mixer for two 
minutes until the sample was fully homogenised. This solution was then 
centrifuged at 500rpm (56g) for 15 minutes in a Heraeus Megafuge 40R 
centrifuge (Thermo Scientific) to separate out the solid matter. The aqueous layer 
was poured into a new sterile universal tube and centrifuged at 3500rpm (2739g) 
for a further 30 minutes to pellet bacteria. The supernatant was discarded, and 
the pellet containing bacteria re-suspended in 1ml of M9 buffer. All centrifugation 
steps were performed at 4°C to limit the growth of bacteria during the process.   
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G. mellonella injection with whole soil communities 
Boxes of Galleria mellonella larvae in the last instar before pupation were 
obtained from UK Waxworms Ltd (www.uk-waxworms.co.uk) and stored in a cold 
room at 4°C prior to injection. All larvae used for this study were used within two 
weeks of purchase. For each sample to be injected, ten larvae were placed in a 
petri dish and kept on ice for a minimum of ten minutes prior to injection to render 
the larvae immobile and unconscious. A Hamilton 50μl syringe (model 80950) 
was sterilised via flushing with 70% ethanol, then flushed with M9 to remove 
residual ethanol. 10μl of each microbial community extracted from our soil 
samples was injected into the hind right proleg of ten larvae. Each person 
performing injections also injected a further ten larvae with 10μl of M9 as a control 
for mortality caused by the injections themselves. Ten additional larvae were left 
uninjected to control for any natural mortality. All larvae were then incubated at 
37°C for 24hrs and mortality recorded. The criteria for determining mortality were 
to first identify larvae that had become visually immobile, these were easily 
detected as they were usually also heavily melanised. Larvae were then touched 
on the head with forceps, and if no movement was detected they were deemed 
deceased. Following the mortality assay all larvae involved were immediately 
frozen at -80°C for a minimum of one hour prior to disposal. Microbial 
communities that caused >50% mortality were deemed to be ‘virulent’. These 
samples were then passed through a Corning® 0.2μm sterile syringe filter before 
being injected into fresh larvae using the same procedures, to exclude any 
mortality due to anything the size of a bacterium or larger. Filtered samples that 
still caused mortality would have been assumed to be caused by chemicals 
present and excluded from further analysis, however this did not apply to any of 
our samples.  
Pathogen clone isolation 
Virulent soil communities causing >50% larvae mortality in were injected into ten 
fresh larvae per sample as per the above procedure, and monitored regularly 
during incubation at 37°C. Individuals showing clear signs of being heavily 
infected were selected for hemocoel extraction. Level of infection was judged by 
the degree to which the larvae melanised (a strong indicator of infection), with 
very dark but still motile larvae being chosen, due to the fact that hemocoel 
becomes difficult to extract post-mortem. A minimum of two infected larvae were 
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selected per soil sample and placed in an Eppendorf tube at 4°C prior to 
hemocoel extraction. Larvae were then placed on ice for at least ten minutes prior 
to extraction. Forceps, blade forceps and cotton buds were sterilised with ethanol. 
Each larva was sterilised around the hind right proleg (the injection site) using a 
cotton bud, and an incision was made at the injection site – enough to allow 
hemocoel to exude without puncturing the gut. Hemocoel was allowed to exude, 
collected with a pipette, and mixed in 400μl M9. Larvae were then immediately 
euthanised by freezing them at -80°C. 
Hemocoel extractions were diluted x10-1, -2 and -3 in LB broth, plated on LB agar, 
and incubated overnight at 37°C. Following colony growth, distinct colony 
morphologies on each plate were identified, and a minimum of one of each 
morphological type observed (Figure S2 and Table S2) was streaked on fresh LB 
agar and incubated overnight to try and isolate it. Following successful isolation 
of each morphology an overnight culture of each was prepared by inoculating a 
single colony in 10ml LB broth and incubating at 37°C. Freezer stocks of these 
clones were made using 0.7ml of 50% glycerol and 0.7ml of overnight culture. 
Each overnight culture was plated on LB agar at a range of dilutions and 
incubated at 37°C overnight. The plate with the highest number of CFU’s that 
could still be visually distinguished by eye was counted with the aid of a Stuart® 
SC6PLUS colony counter. Counts were scaled up proportionally to the amount 
they were diluted by to estimate the CFU concentration in 1ml of overnight 
culture. 
Naming conventions used for isolated soil clones 
All clonal soil isolates obtained from G. mellonella larvae hemocoel were named 
using the following methods, in the order in which they are stated. Firstly, the site 
from which its soil sample was taken e.g. P1. Secondly, the arbitrary number of 
the larva from which hemocoel was extracted from for that soil community, i.e. 
1st, 2nd etc. Thirdly, an arbitrary number based on the order in which the clone 
was obtained from each plated hemocoel extraction. For example P11.1 refers to 
a clone isolated from site P1, the first hemocoel extraction for that community, 
and the first clone isolated from that hemocoel. This naming nomenclature was 
extended for ‘G’ samples, to indicate whether the sample was from the grass-root 
soil (R) or from the paired bulk soil sample (S). For example G6R3.3 refers to a 
clone isolated from site G6, grass-root soil, third hemocoel extraction, and the 
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third clone isolated from that hemocoel. A final name extension was added in one 
particular case where a clone displayed a different morphology to that originally 
recorded, to indicate its morphotype. This was clone SO1.1/6, the ‘/6’ indicating 
that the morphology now resembled type 6. Morphological types for each clone 
are otherwise not indicated in their name, and can instead be found in Table S2. 
G. mellonella injection with clonal soil isolates 
Overnight cultures of each clone isolated from virulent (>50% larvae mortality) 
soil communities were diluted in M9 buffer to 105 CFU and injected into fresh 
larvae as per the method described above, with the same M9 and no-injection 
controls. After incubation for a period of twelve hours mortality was recorded. If 
mortality in any control group was >2 the assay was deemed invalid and was 
repeated with fresh larvae. Clones causing >50% larvae mortality were deemed 
‘virulent clones’ and selected for further study. Overnight cultures of selected 
virulent clones were grown overnight from freezer stocks in LB media and diluted 
in M9 buffer to bring the CFU (per injection) to approximately 103, 105 and 107, 
this being calculated from the previously grown plates. 20 larvae were injected 
with 10μl of each diluted overnight culture in the same manner as previously 
described, along with M9 and no-injection control groups. After an initial ten hour 
period of incubation larvae mortality was recorded hourly until either all larvae 
expired, or a period of 37 total hours had passed since injection (Hernandez et 
al., 2019). If mortality in either control group was >2 the experiment was repeated 
with fresh larvae. LD50 was determined as the lowest CFU treatment that caused 
>50% larvae mortality. The same protocol was also used in a similar assay to 
compare virulence between distinct clones, but using just the 103 CFU treatment.  
Species identification of isolated clones using 16s rRNA 
DNA was extracted from overnight cultures of each clone using a “DNeasy® 
UltraClean® Microbial Kit” (QIAGEN). Each extracted DNA sample was amplified 
using the following PCR protocol and reagents. 25μl of Green master mix 
(DreamTaq, Thermo ScientificTM), 5μl of primer mix (consisting of 16s27f: 5’-
AGAGTTTGATYMTGGCTCAG-3’ and 16s1492r: 5’-TACCTTGTTAYGACTT-3’) 
at 4.5μM concentration, 0.5μl of BSA, 18.5μl of PCR-grade water and 1μl of the 
extracted DNA. Thermocycler used was a Veriti 96-well thermal cycler (Applied 
Biosystems). Thermocycler protocol was one cycle of 95°C for five minutes, 30 
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cycles of 95°C for 30 seconds, 48°C for 30 seconds and 72°C for 90 seconds, 
then one cycle of 72°C for ten minutes. Samples were then held at 4°C until 
collection. PCR product was run on a 1% agarose gel with 5μl ETBR per 100ml 
for 35 mins at 120V. Gels were imaged in a Syngene G: Box alongside positive 
and negative controls and a DNA ladder. PCR product was purified using a 
NucleoSpin® Gel and PCR Clean-up kit (Macherey-Nagel). The concentration of 
purified PCR product was quantified using Fluorometric Quantification with a 
QubitTM dsDNA HS assay kit in a Qubit® 2.0 flurometer (Invitrogen) and diluted 
appropriately using PCR-grade H2O. DNA was sent for sequencing at Eurofins 
Genomics (NGS-Laboratory, Anzinger Str. 7a, 85560, Ebersberg, Germany) 
using the ‘TubeSeq’ service with the aforementioned 16s27f primer. Sequence 
data was then trimmed in MEGA (www.megasoftware.net) to remove poor-quality 
reads based on provided sequence quality documentation. Trimmed sequences 
were compared to the NCBI database “16S ribosomal RNA sequences (Bacteria 
and Archaea)” using the nucleotide BLAST program (blast.ncbi.nlm.nih.gov 
/blast.cgi) running the Megablast algorithm to determine the closest species 
match. BLAST results were sorted by total score, coverage, E-value and 
percentage identity, and the top results were recorded. Trimmed sequences were 
subsequently submitted to the NCBI GenBank database for accessioning.  
Phylogenetic analysis of 16s genes 
We conducted a phylogenetic analysis for four major clades found in our 
environmental samples; Bacillus, Serratia, Providencia and Enterococcus. 16s 
rRNA sequences were obtained from the NCBI GenBank database for several 
species within each genus to further clarify the evolutionary relationships of our 
environmental clones. One additional 16s sequence was added as an outgroup 
for each analysis. All analyses were conducted in MEGA-X (Kumar et al., 2018). 
Sequences were aligned using ClustalW with default settings. Evolutionary 
history was inferred using the Neighbour-Joining method (Saitou and Nei, 1987). 
The evolutionary distances were computed using the Maximum Composite 
Likelihood method (Tamura, Nei and Kumar, 2004) with 1000 bootstrap 
replicates. Codon positions included were 1st+2nd+3rd+Noncoding. All 
ambiguous positions were removed for each sequence pair (pairwise deletion 
option).  
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Antimicrobial resistance profiling 
Clones isolated from soil were further examined and differentiated using 
antimicrobial-resistance testing. We tested 32 clones that had previously been 
identified as either Serratia liquefaciens, Providencia alcalifaciens or Aeromonas 
hydrophila. We used the EUCAST (www.eucast.org, 2019) disk diffusion method 
for antimicrobial susceptibility testing (Version 6.0, January 2017) along with the 
following reference strains: Escherichia coli (ATCC® 25922™), Escherichia coli 
(ATCC® 35218™), and Klebsiella pneumoniae (ATCC® 700603™). Overnight 
cultures of each of our clones and reference strains were diluted using 0.85% 
NaCl solution to 0.5 McFarland standard based on optical density at 600nm. Both 
our clones and the reference strains were then plated on Muller-Hinton (MH) agar 
using swabbing in multiple directions to ensure an even spread. 13 different 
antibiotic discs were added on top of the cultures, and plates were incubated at 
37°C for 16-20 hrs. The time between starting dilutions and placing the prepared 
plates in the incubator was kept to a maximum of 15 minutes to minimise cell 
growth. Antibiotics used were OxoidTM antimicrobial susceptibility disks (Thermo 
Scientific™): Cefoxitin (30μg), Cefpodoxime (10μg), Trimethoprim (5μg), 
Piperacillin / tazobactam combination (36μg), Tigecycline (15μg), Ceftazadime 
(10μg), Chloramphenicol (30μg), Amoxycillin / clavulanic acid combination 
(30μg), Aztreonam (30μg), Ciprofloxacin (5μg), Gentamicin (10μg), Ertapenem 
(10μg) and Azithromycin (15μg). Following incubation the diameter of the 
inhibition zone (‘halo’) around each antibiotic disc was measured by eye to the 
closest millimetre using a ruler. Care was taken to consistently measure only the 
zone where zero growth could be detected. Inhibition zones were compared to 
the relevant EUCAST Clinical Breakpoint Tables (v.9.0, 2019) for each species 
that we tested; A. hydrophila to the Aeromonas spp. tables, S. liquefaciens and 
P. alcalifaciens to the Enterobacteriales tables, and interpreted as being either 
sensitive, resistant, or intermediately resistant to each antibiotic.  
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Results 
Environmental soil samples were collected from locations in Cornwall, UK, to 
assess the prevalence and identity of opportunistic pathogens in the soil. We 
used the Galleria mellonella model system as a screen for pathogenic species in 
soil communities, as this species has been shown to have a similar innate 
immune system to mammals. Soil communities that caused >50% G. mellonella 
larvae mortality were investigated further; clones were isolated from these soil 
communities for study and their virulence was assayed. Detailed larvae mortality 
was recorded across a range of time-points for particular clones of interest. 
Isolated clones were further characterised by morphology, 16s sequencing and 
AMR profiling. Figure 1 shows each stage of the study, the results from each of 
these stages are detailed below. 
  
Figure 1: Workflow diagram of the whole project. An overview of the stages 
of this project. Numbers used at each stage are indicated. Boxes in bold text refer 
to a specific heading in this results section, indicated by the number preceding it. 
The exact number of clones isolated from each hemocoel extraction can be found 
in Table S4.   
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1: Suspected pathogens in 29 soil communities 
After collecting our soil samples and extracting the microbial communities from 
them, we used the G. mellonella model to test for virulence. Our soil communities 
frequently caused high levels of larvae mortality (Figure 3: A). Both the M9 and 
no-injection control groups typically showed no larvae mortality, but 1-2 deaths 
were recorded in a control group in two of the assays. Of all 40 soil communities, 
29 caused larvae mortality of >50% (Figure 3: B) – these will henceforth be 
referred to as ‘virulent’ soil communities. To examine whether soil community 
virulence was affected by soil type, sample sites were categorised into one of 
three types depending on the location they were taken - grassy areas, around 
tree roots, or from heavy-metal contaminated land at Wheal Jane. We excluded 
one sample, C4, which did not fall into any of these categories. Data was not 
normally distributed, and so we used a non-parametric test, finding no significant 
difference in larvae mortality between these types of areas (Kruskal-Wallis rank 
sum test, χ2 = 0.55061 and p > 0.75 on 2 d.f, Figure 4). We also compared the 
larvae mortality between paired samples taken from both grass roots and the bulk 
soil directly below them (sampling event ‘G’). We found that there was a 
significant difference in larvae mortality between these two treatments; the 
samples taken from the grass roots caused higher levels of larvae mortality than 
those taken from bulk soil (paired t-test., t = 2.5205 and p < 0.05 on 6 d.f., Figure 
5).  
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Figure 3: Soil community virulence assays.  Mortality of ten larvae following 
inoculation with 10μl of each soil microbial community and incubation at 37°C for 
24hrs. A: Samples frequently caused high levels of mortality; those in red caused 
>50% larvae mortality and were suspected to harbour pathogens. B: 72.5% of 
samples tested fell into this category. Clones from these communities were 
isolated for further study. Full results for each sampling site are in Table S3. 
 
Figure 4: Soil community virulence sorted by sample soil type. Soil 
community virulence assays (Figure 3) separated by the location each soil 
sample was obtained; 25 from grassy areas, seven from metal-contaminated soil 
and seven from around tree roots. We found no significant effect of location type 
on larvae mortality.  
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Figure 5: Soil community virulence of paired root-soil samples. Mortality of 
ten larvae following injection with microbial communities from seven paired soil 
community samples. Red lines connect paired samples. There was a significant 
difference in larvae mortality between communities from grass roots and those 
from bulk soil. All but one of the grass-root communities caused 100% mortality. 
Samples from one site (G5) caused the lowest mortality for both treatments 
(shown as outliers). 
2: High levels of virulence in 115 isolated clones 
29 of our extracted soil communities were suspected to likely harbour pathogens; 
those causing >50% mortality in G. mellonella. We isolated clones from these soil 
communities to investigate the pathogens responsible. A minimum of two 
hemocoel extractions were performed per soil community to increase the 
likelihood of isolating at least one instance of any pathogens present. Clones 
were distinguished visually based on morphology, size and colour into one of 
eleven morphological types (Figure S2 and Table S2). At least one of each 
morphological type present in each hemocoel extraction was isolated. A total of 
66 hemocoel extractions were performed, with at least two clones being isolated 
from each extraction in all but three instances (Table 3). In total we successfully 
isolated 155 clones from the hemocoel of reinjected G. mellonella; the exact 
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number of clones isolated from each hemocoel extraction can be found in Table 
S4. 
 
Table 3: Numbers of clones isolated from G. mellonella hemocoel 
Number of clones isolated 1 2 3 4 5 
Frequency 3 45 11 6 1 
Summary of the frequency at which single or multiple clones were isolated from 
larvae hemocoel. The exact number of clones isolated from each hemocoel 
extraction and the proportion found to cause >50% larvae mortality can be found 
in Table S4. 
 
Larvae mortality was assayed for individual isolated clones, and high levels of 
mortality were frequently recorded (Figure 6). M9 and no-injection controls 
typically showed no larvae mortality, but 1-2 deaths were recorded in a control 
group in two of the assays. 115 (72.4%) of the clones tested caused >50% larvae 
mortality, and the most frequent result was 100% mortality. Clones causing >50% 
larvae mortality were selected for further identification and analysis. There were 
13 instances in which only a single clone from a hemocoel extraction caused 
>50% larvae mortality, and 48 instances where two or more clones caused >50% 
larvae mortality (Table S4). There were also five hemocoel extractions from which 
all isolated clones caused ≤50% mortality. Figure 7 shows the results of these 
clone virulence assays separated by sampling site.  
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Figure 6: Virulence of isolated clones. Mortality of ten larvae following injection 
with 105 CFU of each clone isolated from soil communities that caused >50% 
larvae mortality (Figure 3). Following incubation at 37°C for 12hrs modal larvae 
mortality was 100% (A). Samples highlighted in red caused >50% larvae mortality 
and were selected for further study. 74.2% of the clones tested fell into this 
category (B).  
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 1 
 2 
   3 
Figure 7: Number of clones isolated from each sampling site. The number of clones isolated from larvae hemocoel from 4 
each soil community that caused >50% larvae mortality (Figure 3). Indicated in red are clones that caused >50% larvae mortality 5 
following injection of 105 CFU of each clone, and incubation at 37°C for 12hrs. Those in blue caused ≤50% mortality. This data 6 
is further represented in Table S4 and Figure S3. 7 
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3: Detailed virulence assays for selected clones 8 
To examine the virulence of our clones in more detail we compared larvae 9 
mortality over time for clones found to cause >50% larvae mortality from the first 10 
two sampling events (Table S1). We selected eight clones, choosing where 11 
possible those that showed differences in morphology, virulence and growth rate. 12 
Larvae mortality was recorded hourly between 10-37 hours post-inoculation for 13 
three CFU concentrations of each clone. No larvae mortality was recorded in the 14 
control groups. We plotted the data as survival curves (Figure 8) with the intent 15 
to examine them using Kaplan-meier survival analysis, however we later decided 16 
not to do this analysis due to time constraints. We did however compare the time 17 
taken for each clone dilution to cause 100% larvae mortality. By this metric, five 18 
of the clones (Figure 8: A-E) were similar to one another, with the lowest CFU 19 
treatment causing 100% larvae mortality within approximately 15 hours and 20 
higher CFU treatments causing 100% mortality sooner. 16s sequencing later 21 
determined that all five of these clones were P. alcalifaciens (Table 4). Two 22 
further clones (Figure 8: F-G) took longer to reach 100% mortality, with the 103 23 
CFU of clone F not reaching 100%. These two clones also caused more gradual 24 
larvae mortality than the P. alcalifaciens, and both were later identified as 25 
belonging to the Bacillus genus, though they could not be identified to species 26 
level (Table 4). The final clone tested (Figure 8: H) showed lower virulence still, 27 
with neither the 103 or 105 CFU treatments causing 100% mortality by the end of 28 
the experiment. Unfortunately this clone could not be successfully identified. We 29 
also calculated that the LD50 for clones A-G was 103 CFU, and 107 for clone H. 30 
Clones that were found to have distinct differences in their AMR resistance 31 
profiles - and therefore likely to be genetically distinct - were tested to examine 32 
their relative virulence over 37hrs, in the same manner as those tested in Figure 33 
8. One representative clone from each AMR profile type described in Table 5 was 34 
tested. For this assay we decided to only use the lowest CFU inoculation (103 35 
CFU) as this treatment had previously shown the greatest variation between 36 
clones (Figure 8). One larvae died in the M9 control group after nine hours, no 37 
other mortality was recorded in the controls. We compared the time taken for 38 
each clone to cause 100% larvae mortality, and found that the single Aeromonas 39 
hydrophila clone was the most virulent, causing 100% mortality within twelve 40 
hours (Figure 9: A). Clones of both P. alcalifaciens (Figure 9: B) and S. 41 
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liquefaciens (Figure 9: C) showed consistency in the time taken for their 42 
respective species to cause 100% larvae mortality (15-18hrs and 17-20hrs, 43 
respectively). All clones tested caused 100% larvae mortality within 20 hours, 44 
with the exception of one clone of S. liquefaciens (G7R1.1) which did not reach 45 
100% larvae mortality within the experimental timeframe. We subsequently 46 
analysed the survival data looking for similarities and differences both within and 47 
between each genus (Figure 9: D). Providencia isolates displayed 48 
indistinguishable virulence to one-another, as did the S. liquefaciens isolates 49 
(pairwise comparisons using log-rank test on survival fitted by Kaplan-meier 50 
method, p>0.25 for all comparisons). One Serratia clone (G7R1.1) was markedly 51 
less virulent than the other Serratia clones (pairwise comparisons using log-rank 52 
test on survival fitted by Kaplan-meier method, p<0.05). We also found significant 53 
differences between the Aeromonas, Providencia and Serratia (Figure 9: D); 54 
using a Cox proportional hazards model the hazard ratio for Aeromonas was 55 
higher than other genera, while for Serratia it was the lowest (Cox proportional 56 
hazards model, n=208, 2d.f, p<0.001 between all genera).  57 
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58 
Figure 8: Galleria survival curves for eight pathogenic clones. Survival of 20 59 
G. mellonella following inoculation with 103 (blue), 105 (orange) and 107 (red) CFU 60 
of each clone. Clones A-E were P. alcalifaciens (P11.1, P11.2, P54.2, P14.1, and 61 
P51.1 respectively). F and G were both Bacillus spp. (P54.1 and P12.1, 62 
respectively), and H (SO1.1) was not successfully sequenced.  63 
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64 
Figure 9: Galleria survival curves for AMR-profiled clones.  Survival of 20 larvae following inoculation with 103 CFU of (A) Aeromonas 65 
hydrophila, (B) Providencia alcalifaciens, and (C) Serratia liquefaciens clones isolated from soil. One of each AMR resistance profile found 66 
is represented. D shows the probability of larvae survival at each time point for all three bacterial species, fitted using the Kaplan-meier 67 
method. LD50 for all clones was 103 CFU 68 
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4: Clone identification 69 
All isolated clones were visually separated into one of eleven morphological types 70 
(Figure 10). Each morphotype’s defining characteristics are described in Figure 71 
S2, along with a photographic reference. The most abundant morphological type 72 
was 4-5, accounting for 68% of all clones. This morphology was initially thought 73 
to be two distinct types (recorded as either 4 or 5) but subsequent platings could 74 
not be distinguished from one another. The only distinction initially found between 75 
these two morphologies was colony size, but this was found to vary slightly for 76 
both morphologies. As such morphology 4 and 5 were deemed the same and the 77 
groups merged.  78 
 79 
Figure 10: Clone morphologies. Clones isolated from larvae hemocoel were 80 
plated on LB agar and differentiated by their visual appearance, and separated 81 
into one of eleven morphological types. Two of these types (4 & 5) were later 82 
merged as they were indistinguishable on further platings. Descriptions and 83 
images of each morphology can be found in Figure S2 and the morphology of 84 
each clone found is in Table S2. 85 
 86 
Clones that displayed significant differences between one another in terms of 87 
virulence, morphology and location found were selected for 16s rRNA 88 
sequencing. We preferentially selected to sequence clones that caused >50% 89 
larvae mortality, but a few that did not were also selected. All clones that were 90 
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successfully sequenced are shown in Table 4, along with their closest species 91 
match. All trimmed 16s sequences used for identification were sent to the NCBI 92 
GenBank database, accession numbers are included in Table 4 for all but three 93 
sequences; two of these were rejected due to them being of insufficient length, 94 
and one was rejected for having chimeric sequences. These sequences can 95 
instead be found in Table S5. Following 16s sequencing we determined that 96 
many clones were Serratia spp., predominantly Serratia liquefaciens, but also 97 
Serratia plymuthica and Serratia nematodiphila, along with several which could 98 
not be identified to the species level. We were able to identify several clones as 99 
Providencia alcalifaciens, and Providencia rustigianii. Several members of the 100 
Bacillus genus were also found, but we were unable to accurately define these to 101 
the species level using BLAST results, except in the case of Bacillus megaterium. 102 
Enterococcus spp. including Enterococcus casseliflavus were also present, but 103 
were also difficult to define to species level. Other species found include 104 
Paenibacillus lautus, Citrobacter gillenii, Raoultella terrigena and Aeromonas 105 
hydrophila. The relative frequency of each of these can be found in Figure 11.  106 
  107 
Figure 11: Species identified. 16s rRNA sequencing was used to determine the 108 
species of a minimum of one of each morphology found, along with any showing 109 
variance in virulence or growth rate. Details on specific results can be found in 110 
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A11.2 Serratia liquefaciens* 98.6 (783) 100 0 MN619709 
A12.2 Bacillus spp. 100 (104) 100 2E-49 Too short** 
A12.3 Serratia liquefaciens* 99.61 (776) 100 0 MN619710 
A2 A21.2 Serratia liquefaciens* 99.42 (518) 100 0 MN619711 
A6 
A61.2 Aeromonas hydrophila* 100 (840) 100 0 MN619712 
A62.2 Enterococcus spp. 96.04 (99) 100 1E-41 Too short** 
A63.1 Serratia / Yersinia / Rahnella* 99.78 (451) 100 0 MN619713 
A63.2 Serratia liquefaciens* 99.51 (822) 100 0 MN619714 
A7 
A71.2 Bacillus megaterium 99.28 (417) 100 0 MN619715 
A71.3 Paenibacillus lautus 100 (299) 100 2E-157 MN619716 
A72.2 Bacillus spp. 100 (439) 100 0 MN619717 
A72.3 Serratia / Yersinia / Rahnella* 99.51 (408) 100 0 MN619718 
A73.3 Serratia liquefaciens* 99.76 (822) 100 0 MN619719 
C1 
C11.2 Serratia liquefaciens* 98.94 (659) 100 0 MN619720 
C12.2 Serratia liquefaciens* 98.96 (672) 100 0 MN619721 
C13.1 Serratia liquefaciens* 98.78 (655) 100 0 MN619722 
C13.2 Serratia liquefaciens* 99.24 (785) 100 0 MN619723 
C3 
C31.1 Bacillus spp.* 100 (664) 100 0 MN619724 
C31.2 Bacillus spp.* 100 (767) 100 0 MN619725 
C32.1 Serratia liquefaciens* 99.7 (670) 100 0 MN619726 
C5 
C51.1 Serratia liquefaciens 99.85 (654) 100 0 MN619727 
C52.1 Serratia spp.* 99.61 (507) 100 0 MN619728 
C7 
C71.1 Bacillus spp. 99.82 (548) 100 0 MN619729 
C71.2 Bacillus spp. 100 (498) 100 0 MN619730 
C72.1 Serratia spp. 99.52 (832) 100 0 MN619731 
C72.3 Bacillus spp.* 99.85 (666) 100 0 MN619732 
C8 
C81.1 Serratia liquefaciens* 98.47 (653) 100 0 MN619733 
C81.2 Serratia liquefaciens 99.23 (653) 100 0 MN619734 
C82.1 Serratia liquefaciens 99.39 (654) 100 0 MN619735 
C83.1 Providencia rustigianii* 100 (831) 100 0 MN619736 
C83.2 Providencia rustigianii 100 (654) 100 0 MN619737 
C9 
C91.1 Enterococcus casseliflavus 100 (499) 100 0 MN619738 
C91.3 Enterococcus casseliflavus 100 (651) 100 0 MN619739 
C92.1 Serratia plymuthica 99.75 (533) 76 0 MN619740 
G1 
G1R1.1 Serratia liquefaciens* 99.85 (654) 100 0 MN619741 
G1S1.2 Serratia liquefaciens* 99.85 (653) 100 0 MN619742 
G2 G2S1.1 Serratia nematodiphila* 100 (655) 100 0 MN619743 
G3 
G3R1.1 Serratia liquefaciens* 99.7 (670) 100 0 MN619744 
G3S1.1 Serratia liquefaciens* 99.85 (653) 100 0 MN619745 
G3S1.3 Bacillus spp.* 100 (664) 100 0 MN619746 
G4 G4R1.1 Providencia alcalifaciens* 99.69 (654) 99 0 MN619747 
G5 G5R1.1 Serratia liquefaciens* 99.55 (660) 100 0 MN619748 
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G5R1.3 Bacillus spp.* 99.74 (775) 100 0 MN619749 
G5R2.1 Bacillus spp.* 99.85 (672) 100 0 MN619750 
G5R4.2 Serratia liquefaciens* 99.85 (653) 100 0 MN619751 
G6 
G6R1.1 Raoultella terrigena 100 (318) 100 7E-168 MN619752 
G6R1.3 Serratia liquefaciens 100 (365) 100 0 MN619753 
G6R2.1 Serratia liquefaciens 100 (339) 100 2E-179 MN619754 
G6R3.2 Citrobacter gillenii 100 (449) 100 0 MN619755 
G6R3.3 Raoultella terrigena 100 (309) 100 7E-163 MN619756 
G7 
G7R1.1 Serratia spp.* 99.65 (570) 100 0 MN619757 
G7R2.2 Serratia liquefaciens* 99.84 (613) 100 0 MN619758 
G7S1.2 Serratia liquefaciens* 99.54 (655) 100 0 MN619759 
P1 
P11.1 Providencia alcalifaciens* 99.88 (849) 100 0 MN619760 
P11.2 Providencia alcalifaciens* 100 (832) 100 0 MN619761 
P12.1 Bacillus spp.* 99.42 (863) 100 0 Chimeric** 
P12.2 Bacillus spp.* 100 (667) 100 0 MN619762 
P13.1 Bacillus spp.* 99.55 (880) 100 0 MN619763 
P13.2 Serratia liquefaciens* 98.93 (654) 100 0 MN619764 
P14.1 Providencia alcalifaciens* 100 (652) 99 0 MN619765 
P5 
P51.1 Providencia alcalifaciens* 100 (653) 99 0 MN619766 
P51.2 Providencia alcalifaciens* 99.85 (656) 100 0 MN619767 
P52.1 Providencia alcalifaciens* 99.88 (828) 100 0 MN619768 
P53.1 Providencia alcalifaciens* 100 (680) 99 0 MN619769 
P54.1 Bacillus spp.* 99.89 (884) 100 0 MN619770 
P54.2 Providencia alcalifaciens* 100 (666) 99 0 MN619771 
SO SO1.1/6 Serratia spp.* 99.64 (828) 100 0 MN619772 
The closest species match for the 16s sequence of each clone when compared 113 
to the GenBank database. In cases where several species were equally likely the 114 
closest genus is stated. A63.1 and A72.3 had equal matches for multiple species 115 
of Serratia, Yersinia, and Rahnella. Coordinates, descriptions and maps of each 116 
sampling site can be found in Table S1 and Figure S1. *Clones marked with an 117 
asterisk caused >50% larvae mortality (Figure 6). **Sequences for A12.2 and 118 
A62.2 could not be accessioned due to being of insufficient length, and the 119 
sequences for P12.1 contained chimeric sequences. These sequences can 120 
instead be found in Table S5.  121 
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To further investigate the identity of our isolated clones, we conducted a 122 
phylogenetic analysis using 16s rRNA sequences for each major clade found in 123 
our environmental samples: Bacillus, Serratia, Providencia and Enterococcus 124 
(Figure 12, 13, 14, and 15, respectively). Our sequences were compared to their 125 
closest BLAST matches along with several additional species from within their 126 
clade; clinically relevant and commonly occurring species were favoured for this. 127 
All sequences were aligned using ClustalW in MEGA-X (Kumar et al., 2018). Due 128 
to short lengths for some of our 16s sequences, some sequences had to be 129 
omitted as they could not be aligned with one another; these are indicated in the 130 
figures where appropriate. Trees were constructed using the Neighbour-Joining 131 
method (Saitou and Nei, 1987), and evolutionary distances were computed using 132 
the Maximum Composite Likelihood method (Tamura, Nei and Kumar, 2004) and 133 
are in the units of the number of base substitutions per site. The percentage of 134 
replicate trees in which the associated taxa clustered together in the bootstrap 135 
test (1000 replicates) are shown next to the branches (Felsenstein, 1985). Trees 136 
are drawn to scale, with branch lengths in the same units as those of the 137 
evolutionary distances used to infer the phylogenetic tree. Sequences from 138 
GenBank contain their accession numbers and strain names, sequences from 139 
our isolated clones state the clone name and closest sequence match from 140 
BLAST in brackets.  141 
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 142 
Figure 12: Evolutionary relationships of Bacillus clones. Neighbour-joining 143 
tree of environmental Bacillus based on 16s rRNA sequences and 1000 bootstrap 144 
replicates Clostridioides difficile (strain U 5/41) was used as on outgroup. 145 
Sequences for A12.2, C31.2, A71.3, P12.1, P54.1 and P13.1 were omitted as 146 
they did not sufficiently overlap with the rest of the sequences. The closest 147 
GenBank matches to our environmentally isolated clones are indicated in 148 
brackets. 149 
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 150 
Figure 13: Evolutionary relationships of Serratia clones. Neighbour-joining 151 
tree of environmental Serratia based on 16s rRNA sequences and 1000 bootstrap 152 
replicates Pseudomonas aeruginosa (strain DSM 50071) was used as on 153 
outgroup. Sequences from A72.3 and A63.1 were omitted as they did not 154 
sufficiently overlap with the rest of the sequences. The closest GenBank matches 155 
to our environmentally isolated clones are indicated in brackets. 156 
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 157 
Figure 14: Evolutionary relationships of Providencia clones. Neighbour-158 
joining tree of environmental Providencia based on 16s rRNA sequences and 159 
1000 bootstrap replicates. Bacillus subtilis (strain IAM 12118) was used as on 160 
outgroup. The closest GenBank matches to our environmentally isolated clones 161 
are indicated in brackets. 162 
 163 
Figure 15: Evolutionary relationships of Enterococcus clones. Neighbour-164 
joining tree of environmental Enterococcus based on 16s rRNA sequences and 165 
1000 bootstrap replicates. Lactococcus garviae subspecies bovis (strain 166 
BSN307) was used as on outgroup. Sequence for A62.2 was omitted due to being 167 
<100 base pairs. The closest GenBank matches to our environmentally isolated 168 
clones are indicated in brackets.  169 
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5: 14 AMR profiles found across 32 clones 170 
Antimicrobial resistance is an important factor when it comes to the treatment of 171 
pathogenic bacteria, and so we examined how resistant our environmentally 172 
isolated clones were to 13 different antibiotics and antibiotic combinations (Table 173 
5) using EUCAST standard protocols. These antibiotics were chosen to cover a 174 
wide range of clinically-relevant classes. The clones tested were susceptible to 175 
the majority of these antibiotics. 10/21 clones of S. liquefaciens were susceptible 176 
to all antibiotics, while the remaining clones showed some resistance to 1-2 177 
antibiotics. All P. alcalifaciens tested were resistant to Azithromycin, with some 178 
intermediate resistances to other antibiotics also found. Across all the clones 179 
there were notably multiple instances of resistance to penicillin-based antibiotics 180 
at both intermediate and fully resistant levels, the Amoxycillin / clavulanic acid 181 
treatment in particular being the least effective antibiotic. Comparison of these 182 
resistance profiles to clinical strains investigated by other studies reveals some 183 
significant differences. S. liquefaciens typically show susceptibility to most of the 184 
antibiotics tested, with the exception of Cefoxitin (I/R), Amoxycillin / clavulanic 185 
acid (R), and Azithromycin (R); our clones being less than fully resistant to these 186 
antibiotics suggests that they are not the same as the clinical strains. P. 187 
alcalifaciens strains also show some major differences, with some sources noting 188 
either I or R levels of resistance for Trimethoprim, Chloramphenicol and 189 
Amoxycillin / clavulanic acid, while Azithromycin resistance appears to be typical 190 
for the species. Insufficient information could be found on A. hydrophila 191 
resistances to highlight any significant differences, or lack thereof, in our single 192 
isolated clone.  193 
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S S S S S S S I S S S S S 1 
R1 - - - - S1 S1 - - S1 - - - N/A 
P. alcalifaciens 
S S S S S S S S S S S S R 5 
S S S S I S S I S S S S R 2 
S S S S I S S I S S S I R 1 
S S S S I S S S S S S S R 1 
S S S S S S S I S S S S R 1 
S2,3 S2 S/I/R2 S2 - S2 
S/I/R2 
I3 S4 
S/I/R2 S2,3 S2,3 S2,3,4 - R2 N/A 
S. liquefaciens 
S S S S S S S S S S S S S 10 
S S S S S S S I S S S S S 5 
I S S S S S S S S S S S S 1 
S S S R S S S R S S S S S 1 
S S S S S S S R S S S S S 1 
S S S S S I S I S S S S S 1 
S R S S S S S R S S S S S 1 
I I S S S S S S S S S S S 1 
I/R5 S5 S6 
S5,7 
S/I8 
S6 S5,6 S5,6 
I/R5 
R6,8 
S5,6 S5,6,8 S5,6,7,8 S5,6 R5,6 N/A 
Antibiotic susceptibility profiles of clonal soil pathogens tested against 13 antibiotics using EUCAST protocol. Each row represents a distinct resistance profile. The 194 
number of clones of each profile found is indicated on the right. S: susceptible, R: resistant, I: intermediate resistance, - : no data available. Beneath the AMR profiles 195 
we found are previously reported resistance profiles for the species based on the following references. 1: (Palú et al., 2006), 2: (Stock and Wiedemann, 1998), 3: 196 
(Wang et al., 2014), 4: (Chander, Goyal and Gupta, 2006), 5: (Stock, Grueger and Wiedemann, 2003), 6: (Mahlen, 2011), 7: (Engelhart et al., 2003), 8: (Traub, 2000).  197 
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Discussion 198 
The aims of this study were to screen environmental soil samples for the 199 
presence of virulent human pathogens, to determine whether soil type and 200 
location affected the occurrence of these pathogens, identify the species present, 201 
and determine which were the most virulent, subsequently comparing them to 202 
reported clinical strains. We used the Galleria mellonella model system as a 203 
virulence screen, and were able to screen for the presence of pathogens in 40 204 
soil communities taken from locations in Cornwall, UK, in a manner similar to 205 
Hernandez et al. (2019). G. mellonella injected with extracted soil communities 206 
frequently showed high levels of mortality. The majority of soil communities 207 
obtained caused mortality of >50% in Galleria, and the modal result was total 208 
mortality (Figure 3). This finding suggests that species of human pathogens are 209 
common in soil communities, and highlights the importance of studying and 210 
understanding them. We were subsequently able to selectively isolate and enrich 211 
environmental clones from these samples and characterise them in further 212 
assays, the results of which will be discussed here.  213 
The effect of soil type on the frequency of pathogens  214 
Soil bacteria need to obtain essential resources such as vitamins and minerals 215 
from the soil. Iron in particular is a vital resource, and there is competition 216 
between species and individual bacteria to obtain it. To do so, bacteria use extra-217 
cellular complexes known as siderophores, which bind to the iron and allow it to 218 
be taken into the cell. In pathogenic species, these same siderophores are an 219 
important virulence factor as they are similarly used to gather iron from within the 220 
host species (Hider and Kong, 2010). In environments where iron resources are 221 
scarce, the production of siderophores is upregulated (Boiteau et al., 2016), and 222 
it follows that in these environments selection would favour bacteria which 223 
produce high numbers of siderophores. It is for this reason that we suspected 224 
certain soil types to contain higher frequencies of virulent pathogens than others. 225 
In particular, we suspected soil communities from rhizosphere soil to cause more 226 
Galleria mortality than soil communities from elsewhere; in the rhizosphere the 227 
increased inter and intra-species competition for iron could select for higher levels 228 
of siderophore production. Inversely, we suspected that microbes in iron-rich soils 229 
would likely produce fewer siderophores due to the abundance of resources, and 230 
thus fewer virulent pathogens would be found there. 231 
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In comparing the microbial communities we took from grassy areas, tree roots, 232 
and metal-contaminated soil samples we could find no significant differences in 233 
Galleria mortality (Figure 4). This result does not support our hypothesis, however 234 
this could be due to a low statistical power. Our samples were not systematically 235 
taken with this analysis in mind, and as such we had seven samples from near 236 
tree-roots, seven from metal-rich soils (including two from river-bed soil), but 25 237 
from grass. Future studies seeking to investigate this potential relationship may 238 
find a significant difference if they were to collect equal samples of each soil type, 239 
and ideally greater numbers of samples.  240 
A similar analysis looked at paired the samples taken from grass roots and bulk 241 
soil in the same location (Figure 5), again asking whether there were more 242 
pathogens present in soil communities from one of these soil types. In this case, 243 
we did find a significant difference in Galleria mortality, which was significantly 244 
higher in the communities from grass-roots. This supports the idea that 245 
rhizosphere communities contain more virulent species than other soil 246 
communities. However we were not able to identify whether the higher 247 
frequencies of pathogens noted was due to increased selection for siderophore 248 
production as hypothesised. Future studies could quantify siderophore 249 
production levels to examine whether this is indeed the case. 250 
Community virulence compared to clone virulence 251 
Clones isolated from the soil communities that caused >50% Galleria mortality 252 
generally also caused high levels of mortality (Figure 6). Of 155 clones isolated, 253 
115 (74.2%) caused mortality of >50%, with the 94 of these (60.6%) causing 254 
100% mortality. This shows that in most cases the virulence is not caused by a 255 
single species from the community, but rather that the majority of the community 256 
causes high levels of virulence. This finding is explored further in Figure 7, where 257 
we see that in most cases all clones isolated from a site caused >50% mortality, 258 
and similarly in Table S4 - most or all of the clones isolated from each hemocoel 259 
extraction were found to cause >50% mortality. There are exceptions however, 260 
and this suggests that non-pathogenic species are coexisting with pathogens in 261 
the soil. Intriguingly, none of the clones isolated from site GO caused more than 262 
10% mortality, despite the community sample causing 90% mortality. This could 263 
be due to a number of factors, such as a synergistic effect between multiple 264 
species, or potentially it could be that the causal pathogen was not isolated from 265 
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the community. Future experiments could co-inoculate clones in Galleria to 266 
investigate possible synergistic, or antagonistic relationships between them. 267 
On the prevalence and diversity of pathogenic soil species 268 
The clones we isolated from the 29 soil communities that caused >50% Galleria 269 
mortality were identified via 16s rRNA sequencing. The genera detected were 270 
predominantly Serratia, Providencia and Bacillus, with the most common species 271 
being Serratia liquefaciens and Providencia alcalifaciens (Figure 11). 21 of the 272 
soil communities were found to contain Serratia species, Bacillus species were 273 
present in eight, and Providencia species were in four. We also found 274 
Enterococcus in two samples, and Aeromonas, Citrobacter and Raoultella each 275 
in one sample. Looking at the sites from which each genus was found (Figure 16) 276 
gives us some idea of the patterns of genus co-occurrence within the soil. Serratia 277 
spp. were present in all but three sites, and were frequently found in isolation. 278 
Providencia were also found in isolation, but also co-occurred with Serratia and 279 
Bacillus. Bacillus by contrast was never found in isolation, and was predominantly 280 
found with Serratia. Interestingly, Enterococcus was only found in combination 281 
with Serratia, and Aeromonas was only found in a single site (A6) which 282 
contained both Serratia and Enterococcus. This could suggest some form of 283 
mutualistic relationship between the three genera. 284 
It is interesting to note the common occurrence of Serratia across the majority of 285 
sampling sites, as these have not been noted as being particularly prevalent in 286 
soils previously. Berg, Eberl and Hartmann (2005) did note the occurrence of 287 
Serratia spp. in the rhizosphere of oilseed rape, but found no instances where it 288 
occurred outside that environment; our study clearly shows that this is not the 289 
case. Janssen (2006) describes the dominant soil bacterial taxa found in 16S 290 
rRNA libraries, and notes that Gammaproteobacteria, the clade to which Serratia 291 
belongs, has a mean prevalence of 8.1% across 194 samples, but does not 292 
indicate the prevalence of specific genera. Other studies have looked at overall 293 
species richness (Lozupone and Knight, 2007), soil microbial community 294 
structure (Fierer et al., 2005) or the prevalence of specific genes in specific soil 295 
types (Byrne-Bailey et al., 2011), but little information could be found on typical 296 
species prevalence based on 16s in uncultivated soils. 297 
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Figure 16: Sites where each genus was identified. Sampling sites from which 299 
each genus of bacteria was detected. Overlapping clades indicate that clades co-300 
occurred in the soil sample sites indicated. Only sites from which the community 301 
samples caused >50% Galleria mortality and clones were successfully 302 
sequenced were included. *We also detected a Citrobacter and Raoultella in 303 
infections following inoculation from the site G6 sample. 304 
Detailed virulence assays of detected pathogens 305 
Galleria mortality was recorded over 37hrs following inoculation with 103, 105 and 306 
107 CFU of eight pathogenic clones (Figure 8). These clones were chosen from 307 
clones from the first two sampling events that caused >50% larvae mortality 308 
(Table S1), preferentially choosing clones that displayed differences in 309 
morphology, virulence and growth rate, to attempt to examine a range of 310 
pathogens. Based on the time taken for these clones to cause 100% larvae 311 
mortality, the five clones later identified as P. alcalifaciens show the least 312 
virulence of the species tested, with the 107 CFU treatment causing 100% 313 
mortality within 13 hours, and the 103 CFU treatment doing so within 18 hours 314 
(Figure 8). The two Bacillus clones (F & G) analysed had noticeably different 315 
survival curves to both the P. alcalifaciens and to one-another (Figure 8). Clone 316 
F showed a similar time to the P. alcalifaciens clones for 100% mortality to be 317 
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reached, however survival at earlier time points was generally lower than the P. 318 
alcalifaciens (60% after 10 hours for the 103 CFU treatment), suggesting higher 319 
virulence in the first few hours following inoculation. The 103 CFU treatment for 320 
Clone G did not reach 100% mortality within our experimental timeframe, which 321 
could possibly indicate that it was a different species of Bacillus to clone F. Clone 322 
H was the least virulent of the eight clones tested, with only the 107 CFU treatment 323 
reaching 100% mortality, while the 103 treatment caused none at all. This 324 
suggests it was a different species, or at least a different genotype, to all the other 325 
seven clones tested, but unfortunately it was not successfully sequenced. These 326 
results go some way to showing that there is consistency in virulence within the 327 
species found. 328 
Galleria mortality curves were recorded for clones identified as Aeromonas 329 
hydrophila, Providencia alcalifaciens, and Serratia liquefaciens, following AMR 330 
profiling (Figure 9). One representative clone of each AMR resistance profile was 331 
chosen for inoculation, and only the 103 CFU treatment was used as this had 332 
shown the greatest difference between clones in the previous experiment. We 333 
compared the time taken to cause 100% mortality for each clone, finding that A. 334 
hydrophila was the most virulent. All P. alcalifaciens clones caused 100% 335 
mortality within 15-18hrs, while all Serratia did so within 17-20hrs, with the 336 
exception of one (G7R1.1). Analysing the survival data using the Kaplan-meier 337 
method provided further evidence that of the three species represented, A. 338 
hydrophila was the most virulent, followed by P. alcalifaciens, and S. liquefaciens. 339 
Intra-species variation was generally not significant (pairwise comparisons using 340 
log-rank test on survival fitted by Kaplan-meier method, p>0.25 for all 341 
comparisons), with the exception of one clone of S. liquefaciens, G7R1.1, which 342 
caused lower mortality (pairwise comparisons using log-rank test on survival fitted 343 
by Kaplan-meier method, p<0.05). G7R1.1 was subsequently sent for whole-344 
genome-sequencing (results not included in this document) and identified as a 345 
singular isolate of Serratia plymuthica. Incidentally, our 16s sequencing also 346 
identified a single S. plymuthica (C92.1) from the other clones found (Table 4) 347 
which showed no virulence in its’ mortality assay. These findings suggest that S. 348 
plymuthica may have lower virulence than S. liquefaciens, though we could find 349 
no existing literature to support this hypothesis, possibly due to the rarity of S. 350 
plymuthica infections. Finally a Cox proportional hazards model was used to 351 
further examine the differences between the survival curves of the three genera 352 
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tested, finding that Aeromonas was significantly more virulent than the others, 353 
while Serratia was the least virulent of the three (Cox proportional hazards model, 354 
n=208, 2d.f, p<0.001 between all genera).  355 
The relevance of Serratia to human infection 356 
Serratia species and Serratia marcescens in particular are known to be significant 357 
human pathogens (Mahlen, 2011). S. marcescens is a well-known opportunistic 358 
pathogen of the immunocompromised in hospitals, and although it generally 359 
displays low virulence it can cause UTI’s, conjunctivitis, respiratory tract infections 360 
and bloodstream infections (Cristina, Sartini and Spagnolo, 2019) and was 361 
infamously used by the U.S. military as to experimentally test susceptibility to, 362 
and viability of, biological warfare attacks (Mahlen, 2011). Infections by S. 363 
liquefaciens, the bacterium most commonly found in our environmental samples, 364 
are relatively rare compared to S. marcescens infections, but are still the “second 365 
most common Serratia species involved in human infections” (Mahlen, 2011). 366 
Various reports have found S. liquefaciens in bacteremia, UTI’s, endocarditis, 367 
meningoencephalitis and abscesses. Typically infections appear to be from an 368 
environmental source, although hospital acquired infections have been noted 369 
when equipment has become contaminated (Ikumapayi et al., 2016). S. 370 
liquefaciens has even been noted to infect immunocompetent people (Gutiérrez-371 
González, Peteiro and Toribio, 2014). Worryingly, S. liquefaciens has 372 
increasingly been noted as a cause of transfusion‐related sepsis via 373 
contaminated blood, and fatality rates in such cases are high (Roth et al., 2000). 374 
Because of its rarity an accurate diagnosis of S. liquefaciens can take significantly 375 
longer than other species, delaying effective treatment (Helvaci et al., 2019). 376 
However if correctly diagnosed S. liquefaciens is usually susceptible to a wide 377 
variety of antibiotics (Traub, 2000; Stock, Grueger and Wiedemann, 2003; 378 
Samonis et al., 2017), and the spread of infection is relatively easy to combat so 379 
long as adequate hygiene standards are maintained (Engelhart et al., 2003). The 380 
clones we isolated from soil communities seem to be more susceptible to 381 
Azithromycin, Cefoxitin and Penicillin combination treatments than is generally 382 
reported, with the most common antibiotic profile found being susceptible to all 383 
antibiotics tested (Table 5). This could be due to a lack of resistance genes 384 
acquisition, or the loss of resistance genes due to selective pressure from the 385 
environment, and suggests that environmentally acquired S. liquefaciens 386 
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infections would be easily treatable. Our 16s results also suggest that S. 387 
plymuthica and S. nematodiphila were present, in our environmental samples. S. 388 
plymuthica has been noted as a human pathogen (Carrero et al., 1995), albeit far 389 
more rarely than other Serratia, whereas S. nematodiphila is rare amongst the 390 
Serratia in that it has not yet been reported as a human pathogen (Erem et al., 391 
2019), instead being known to form symbioses with an entomopathogenic 392 
nematode (Zhang et al., 2009). The presence of both of these species is therefore 393 
likely to pose a minimal threat to human health. 394 
The relevance of Providencia to human infection 395 
Providencia infections in humans seem to be relatively rare in general and are 396 
often nosocomially acquired. Providencia are opportunistic human pathogens, 397 
and infections are typically due to either Providencia stuartii, which can cause 398 
UTI’s, or Providencia rettgeri, which is often implicated in cases of diarrhoea (Yoh 399 
et al., 2005). P. alcalifaciens, which we found, seems to be less common, but is 400 
also a causative agent of diarrhoea (Haynes and Hawkey, 1989) and seems to 401 
often be acquired through contaminated food (Murata et al., 2001; Shah et al., 402 
2015). Providencia spp. in general seem to be prone to acquiring resistance to 403 
antibiotics, particularly ESBL’s (Overturf, Wilkins and Ressler, 1974; Tumbarello, 404 
2004). The fact that Providencia can be a commensal gut bacterium also means 405 
that it’s potential as a pathogen can be overlooked.        406 
The relevance of Aeromonas to human infection 407 
Aeromonas species have been emerging as human pathogens over the last few 408 
decades (Batra, Mathur and Misra, 2016). Typically they are strongly associated 409 
with water, and human infection occurs via ingestion of contaminated food 410 
sources such as fish and prawns (Wang and Silva, 1999; Vivekanandhan, Hatha 411 
and Lakshmanaperumalsamy, 2005; Praveen et al., 2016). Aeromonas is most 412 
commonly recovered from the gastrointestinal tract and known to cause acute 413 
gastroenteritis, it is also often associated with diarrhoea, although doubts remain 414 
as to whether it is the causative agent in these cases (Janda and Abbott, 2010). 415 
Rarely, it has also been known to cause sepsis, meningitis and necrotizing soft 416 
tissue infections, which can potentially be fatal (Parras et al., 1993; Lin and 417 
Cheng, 1998; Richards et al., 2015). The fact that we only isolated a single clone 418 
of A. hydrophila from our environmental samples suggests that it is relatively rare 419 
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in the soil microbiome, however this sample was taken from close to a river, and 420 
could possibly be an indication that the water source itself was contaminated, 421 
potentially warranting further investigation. This site was also one of the heavy-422 
metal contaminated sites, though it is unclear whether this has any bearing on 423 
the presence of A. hydrophila. 424 
The relevance of Enterococcus to human infection 425 
It is also interesting to note the occurrence of Enterococcus spp. and specifically 426 
Enterococcus casseliflavus in our environmental samples. Galleria injected with 427 
all identified clones of Enterococcus showed no mortality whatsoever, and while 428 
Enterococcus are relatively avirulent, they are known to be opportunistic 429 
pathogens in humans (Reid, Cockerill and Patel, 2001). Commonly found in 430 
UTI’s, Enterococcus spp. also have the potential to cause potentially life-431 
threatening diseases. In cases where Enterococcus infections lead to bacteremia 432 
the mortality rate can be between 26% and 46%, and from endocarditis can be 433 
between 9-15% (Agudelo Higuita and Huycke, 2014). Additionally, Enterococcus 434 
spp. typically display high levels of antibiotic resistance, with many strains being 435 
resistant to multiple drugs including Vancomycin (CDC, 2013). Thus the strains 436 
we detected could still potentially pose a threat to human health, and it is 437 
important to note that soil could be a potential source. It is unclear as to why there 438 
was no Galleria mortality, it is possible that the effects of Enterococcus spp. 439 
infection were not detectable in the time allowed by the experiment, or the 440 
conditions for optimal growth were not met. Indeed, it seems probable that 441 
detection of Enterococcus spp. from our environmental samples would not have 442 
happened if they had not co-occurred with other, detectably virulent pathogens. 443 
Alternatively, these species could suggest contamination from the natural 444 
microbiome of G. mellonella; Enterococcus gallinarum / saccharolyticus is known 445 
to be a common gut commensal of insects and has been found to be prevalent in 446 
Galleria (Allonsius et al., 2019). Indeed, our phylogenetic analysis of 447 
Enterococcus (Figure 15) suggests that our clones are quite closely related to E. 448 
gallinarum, providing evidence to suggest contamination of our samples with 449 
internal gut flora.  450 
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The relevance of Bacillus to human infection 451 
A number of virulent Bacillus were detected in our soil samples. We compared 452 
the 16s sequences we obtained to a number of Bacillus spp. (Figure 12). These 453 
phylogenetic analyses suggest that all of the Bacillus isolated that could not be 454 
identified to species level were members of the Bacillus cereus group. This could 455 
be a potential cause for concern, as some species in that group are highly 456 
pathogenic. B. cereus sensu stricto is a known human pathogen, often 457 
responsible for food poisoning and known to cause vomiting and diarrhoea 458 
(Granum and Lund, 2006). B. anthracis is closely related to B. cereus, and is an 459 
extremely potent human pathogen that has been used as a bioweapon (Spencer, 460 
2003). B. thuringiensis (or Bt) is a potent entomopathogen, and is often used as 461 
a biological pesticide due to the Cry toxins it produces. The effects of Bt in 462 
mammals are still the subject of some debate (Rubio-Infante and Moreno-Fierros, 463 
2016). The main differences between these species are the presence of plasmid-464 
borne toxins in both B. anthracis and B. thuringiensis (Ivanova et al., 2003). It 465 
would be wise for future studies to clarify whether the clones we isolated are one 466 
of these species, or one of the less harmful members of the B. cereus group. 467 
Potential risk factors for infection 468 
While we detected the presence of the aforementioned pathogen species, they 469 
do not directly pose a threat to human health while contained within soil. However 470 
there are many potential ways in which these pathogens could infect a human 471 
host and cause disease. Here we briefly mention some potential routes to 472 
infection. 473 
One potential avenue for infection has already received a fair amount of study, 474 
that of infected food crops. Several studies have found examples of bacterial 475 
species mentioned in Table 1 in a variety of plant rhizospheres including oilseed 476 
rape, potatoes, maize, wheat and rice (Berg, Eberl and Hartmann, 2005). 477 
Pathogens such as these can be taken in through plants roots and internalised, 478 
particularly in unhealthy or damaged plants (Hirneisen, Sharma and Kniel, 2012). 479 
Fruit and vegetables can then serve as a vector for important pathogens such as 480 
E. coli and Salmonella (Berger et al., 2010). 481 
Another source of infection includes gardening and farming accidents which often 482 
happens as a result of skin penetration by splinters, thorns or tools. Such 483 
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accidents can cause deep tissue wounds, contaminated by soil or faecal matter, 484 
and are known to be a source of tetanus, caused by the bacterium Clostridium 485 
tetani (Baker et al., 2009). While C. tetani is a dangerous pathogen, infections 486 
can generally be avoided through adequate precautions such as protective 487 
gloves and vaccination. 488 
Geophagia (the direct ingestion of soil) is also a significant route of infection. It is 489 
often associated with unhygienic children (Shivoga and Moturi, 2009; Gotkowska-490 
Płachta and Korzeniewska, 2015) who unwittingly intake soil matter, but it can 491 
also result from less obvious situations such as outdoor sports. Indeed there are 492 
anecdotal reports of large groups of people being infected by accidental soil 493 
ingestion at muddy events such as motorcycle races and obstacle courses (The 494 
Telegraph, 2015). Geophagia can also be due to mental illness or in certain 495 
cultures it can actually be a deliberate traditional practice (Woywodt and Kiss, 496 
2002).  497 
A more indirect route of infections can be found in the leaching of soil pathogens 498 
into other environments such as water systems and even the air. Depending on 499 
the use and management of the land, soil can slowly be damaged and eroded by 500 
a number of factors including irrigation, evaporation, wind and agricultural 501 
practices (Wall, Nielsen and Six, 2015). In this way soil pathogens could spread 502 
to and contaminate other environmental reservoirs. Appropriately managing land 503 
use to avoid this erosion is important to prevent such contamination (Wall, 504 
Nielsen and Six, 2015)  505 
Comments on the Galleria mellonella virulence model 506 
This study is consistent with Hernandez et al. (2019) in showing that the Galleria 507 
model can be used to selectively isolate and enrich pathogens from the soil, and 508 
identify novel pathogens that would be missed by more traditional techniques. 509 
The Galleria model is still relatively new compared to traditional mammalian 510 
model systems, and is still being developed in some major areas. For example 511 
the immune system of Galleria is still being studied in order to further understand 512 
it (Pereira et al., 2018). On a practical level, while Galleria can be bought in bulk 513 
from external suppliers for relatively little expense, this does come with a trade-514 
off: there could potentially be issues with the consistency of studies when using 515 
Galleria acquired from outside sources. Suppliers do not breed the larvae under 516 
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standardised conditions, and often use antibiotics or preservative agents to keep 517 
the Galleria fresh and sterile, which may bias the results of experiments using 518 
them (Allonsius et al., 2019). To remedy this, efforts are being made to create 519 
lab-reared strains with consistent breeding conditions and without using any 520 
antibiotics or preservatives in the process such as TruLarvTM (Bio Systems 521 
Technology), although this is currently an expensive option for high - throughput 522 
experiments such as virulence assays. There is also a lack of standardised 523 
experimental conditions and procedures between individual research labs that 524 
needs to be addressed to improve consistency of studies (Tsai, Loh and Proft, 525 
2016). More research is also needed into the microbiome and genetics of Galleria 526 
to understand them and the microbes that they carry more thoroughly.  527 
Limitations of the project 528 
It is important to note the limitations of such a study to clarify any misconceptions 529 
and lay the groundwork for future experiments. One important element to mention 530 
is that the numbers of each species detected do not accurately correspond to the 531 
proportions in which they would naturally exist within the soil. This was never an 532 
intended outcome of our study, instead being simply to detect and characterise 533 
some of the species present. Due to the way in which we performed hemocoel 534 
extractions, isolating each morphology at least once, many of the clones isolated 535 
were likely replicates of one another. This means that data such as that presented 536 
in Figure 11 is simply a representation of the frequency of species successfully 537 
recovered, and not the original frequencies. Future studies seeking to determine 538 
these relative frequencies would benefit from a more systematic approach to 539 
pathogen isolation, or simply performing metagenomics analysis on whole-540 
community samples. 541 
Additionally, some pathogenic species may simply not have been successfully 542 
extracted from the soil samples. Our method for extracting the soil communities 543 
may have left some microbes still attached to soil particles, potentially omitting 544 
some species from our analysis. It is also interesting to note the complete 545 
absence of any species of fungi from our samples. Soil, and the rhizosphere in 546 
particular, certainly contains many fungal species (Frac et al., 2018), so this 547 
seems somewhat anomalous. One explanation for this could be the type of 548 
growth media used; while LB is able to culture a wide range of microbial species, 549 
there are also many which do not grow on it. The range of bacterial species found 550 
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would also almost certainly vary depending on the growth media, and future 551 
experiments would do well to use several media types for this reason. 552 
It is important to clarify that, our method of selecting microbial communities and 553 
clones causing >50% Galleria mortality for further study was an arbitrary cut-off 554 
point, used simply for the purpose of isolating and identifying the most virulent 555 
pathogens. This is not to say that communities and clones displaying less 556 
virulence were not dangerous. Those causing less virulence in our assays could 557 
still have severe detrimental effects, and future studies may wish to investigate 558 
this further. For example, Enterococcus species are known human pathogens 559 
(Reid, Cockerill and Patel, 2001), and yet in our assays no Galleria mortality was 560 
recorded from any of the Enterococcus found. One possible explanation for this 561 
is that slow-acting pathogens would likely not have been found within the 562 
timescales we used. It is likely that assays run over a greater amount of time 563 
would be able to detect a greater range of pathogens for this reason. 564 
It is also unfortunate that some of our 16s sequences were of poor quality, several 565 
clones could not be identified due to the quality of their reads, either due to being 566 
too short or having too many uncertain bases in the sequence. Of those that were 567 
successfully sequenced, three could not be accepted for accessioning by 568 
GenBank – two were too short and one was determined to contain chimeric 569 
sequences. These issues could be due to a number of factors including our 570 
handling of the DNA extractions and amplifications, errors in the sequencing 571 
itself, or something that happened in transit. It is possible that under different 572 
circumstances we could have improved sequence quality, and thus have been 573 
able to identify our clones with a greater degree of accuracy. 574 
Concluding remarks 575 
In this study we detected pathogenic bacteria very frequently across all the soil 576 
types and locations sampled. The vast majority of these bacteria were also found 577 
to be highly virulent when isolated from their soil communities. The species 578 
detected include several known human pathogens of clinical relevance, including 579 
S. liquefaciens, P. alcalifaciens, A. hydrophila and species in the B. cereus group. 580 
The extreme biodiversity of soil environments suggests that samples taken from 581 
other soil types and locations would vary greatly in the diversity of pathogen 582 
species, and it would be interesting to determine whether the species we found 583 
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are a localised phenomenon or typical of soil environments in general. We hope 584 
that future experiments will be able to clarify this. While this study cannot hope to 585 
provide a comprehensive overview of all the pathogenic species present in soil, 586 
it provides a small glimpse at the pathogenic potential of species in the soil 587 
microbiome, which thus far have been relatively unknown. We hope that this 588 
highlights the needs for further studies in this area and helps in building a more 589 
complete understanding of the soil as a reservoir for pathogenic species.   590 
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Supplementary material 591 





Coordinates Location description Location type 
29/08/2018 
GO 50.14386, -5.06939 
Patch of grass near 
Gyllingvase beach 
Grass 
BO 50.16017, -5.07415 
Grass verge near Greenbank 
hotel 
Grass 
SO 50.13619, -5.07767 
Coastal path near Swanpool 
beach 
Grass 
PO 50.16961, -5.09872 Close to Penryn estuary Grass 
17/09/2018 
P1 50.16987, -5.1237 
Woods in front of Tremough 
House 
Tree 
P2 50.17003, -5.12522 Tremough House gardens Grass 
P3 50.16922, -5.12468 
Vegetable garden near the 
Performance Centre 
Grass 
P4 50.17028, -5.12323 
Open field in front of 
Tremough House gardens 
Grass 
P5 50.17238, -5.11719 
Sunken garden by pedestrian 
entrance to campus 
Grass 
P6 50.16804, -5.12098 




C1 50.17131, -5.12859 
Unused grass plot next to 
Tremough Innovation Centre 
Grass 
C2 50.17076, -5.12716 
Beneath the Eucalyptus in 
front of the Environment and 
Sustainability Institute 
Tree 
C3 50.16736, -5.12592 
Open field close to the 
campus Sports Centre 
parking lot 
Grass 
C4 50.16985, -5.12781 
Old Cornish stone wall by the 
A39 entrance to campus 
Unclassified* 
C5 50.16985, -5.12329 
Wood in front of Tremough 
House 
Tree 
C6 50.16922, -5.12307 
Forested area next to the 
Performance Centre 
Tree 
C7 50.16999, -5.12126 
Grass verge near main path, 
close to trees 
Tree 
C8 50.17055, -5.12027 
Grass verge at path 
intersection 
Grass 
C9 50.1715, -5.11858 
Grass verge close to main 
path through campus 
Grass 
22/10/2018 
G1R&S 50.16766, -5.12574 
Open field close to the 
campus Sports Centre 
parking lot 
Grass 
G2R&S 50.16977, -5.12286 
Forested area in front of 
Tremough House 
Tree 
G3R&S 50.17033, -5.12053 Grass verge by main path Grass 
G4R&S 50.17035, -5.11996 Footpath over small stream Grass 
G5R&S 50.17209, -5.12262 Campus playing field Grass 
23/10/2018 
G6R&S 50.17131, -5.12859 
Unused grass plot next to 
Tremough Innovation Centre 
Grass 
G7R&S 50.17093, -5.12698 
In front of the Environment 
and Sustainability Institute 
Grass 
05/11/2018 A1 50.23242, -5.13296 Wheal Jane river bank 
Metal-
contaminated 
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A2 50.23242, -5.13297 Wheal Jane river bank 
Metal-
contaminated 
A3 50.22996, -5.12738 Wheal Jane 
Metal-
contaminated 
A4 50.22996, -5.12713 Wheal Jane 
Metal-
contaminated 
A5 50.23013, -5.12725 Wheal Jane 
Metal-
contaminated 
A6 50.23009, -5.12706 Wheal Jane 
Metal-
contaminated 
A7 50.23022, -5.12713 Wheal Jane 
Metal-
contaminated 
Exact locations of each sampling site as determined via GPS coordinates, and a 593 
brief description of the site. Each site was categorised into one of three types 594 
based on the area: areas of grass, tree roots, or heavy-metal contamination. *Site 595 
C4 could not be categorised as any of these and was omitted from analyses using 596 
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 602 
Figure S1: Maps of sampling sites. Maps indicating the locations of our 603 
sampling sites. A) Falmouth, Cornwall, UK. B) University of Exeter, Cornwall 604 
Campus, Penryn, UK. C) Wheal Jane, Cornwall, UK. Map D shows where maps 605 
A, B, and C are located in a wider context. Major towns and cities are highlighted. 606 
Original images c/o Google Maps 2019 (maps.google.com).  607 
D 
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Figure S2: Images and descriptions of clone morphologies. Microbial 608 
colonies isolated from soil samples using Galleria hemocoel extraction. Eleven 609 
1 2
  1 
3 
4 5 6 
7 8 9 
10 11 
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visually distinct colony morphologies were found. A brief description of each 610 
follows.  611 
1 – Wide, flat, slightly ‘fuzzy’ colonies. Sequencing determined that these were 612 
typically species of Bacillus.  613 
2 – Hard, closely-spaced, ‘wrinkly’ colonies. Found to be either Bacillus 614 
lichenformis, Providencia alcalifaciens, or another undetermined Bacillus 615 
species.  616 
3 – ‘Blobby’ colonies with a wet appearance, slightly whiter than other morphs. 617 
Only 2 examples of this were found and they were not chosen for sequencing. 618 
4 and 5 – White, round colonies. While initially we seperated 4 and 5 based on 619 
slight variations in size, later platings showed that the two were in fact 620 
indistinguishable from one another and thus were merged. These were the most 621 
common colony morphology and were typically Providencia alcalifaciens.   622 
6 – Round colonies with a distinct whitish colour. We found that they were Serratia 623 
species.  624 
7 – Very small round colonies, somewhat transparent. Isolates caused no 625 
mortality. Determined to be Enterrococcus casseliflavus.  626 
8 – ‘Egg-shaped’ colonies with a distinct two-tone colour. These were Serratia 627 
nematodiphila.  628 
9 – Very small round colonies, quite similar to #7 except for colouration. 629 
Unfortunately 16s sequencing results were poor and this morph could not be 630 
identified.  631 
10 – Large, round, white colonies. Somewhat similar to #4/5, except noticably 632 
larger and more opaque. Found only once and identified as Aeromonas 633 
hydrophila.  634 
11 – a singular isolate that ‘swarmed’ across the plate. Exclusively found 635 
alongside the large white colony shown, and inseperable from it. Sequencing 636 
revealed it to be Paenibacillus latus. 637 
 638 
  639 
P a g e  77 
P a g e  77 
Table S2: Morphology of each clone 640 
Morphology 
number 
Clones displaying this morphology 
1 
P11.3, P11.4, P11.5, P12.1, P12.3, P12.4, P13.1, P54.1, C31.1, 
C31.2, C72.1, C72.3, G3S1.3, G5R1.2, A72.2 
2 P11.2, P12.2, A12.2 
3 P54.3, SO1.2 
4-5 
P11.1, P13.2, P14.1, P51.1, P51.2, P51.3, P52.1, P53.1, P54.2, 
GO1.1, GO1.2, GO1.3, GO1.4, C11.1, C11.2, C12.1, C12.2, 
C13.1, C13.2, C32.1, C32.2, C51.1, C51.2, C52.1, C52.2, C53.1, 
C53.2, C71.1, C71.2, C72.2, C81.1, C81.2, C82.1, C82.2, C83.1, 
C83.2, C91.2, C92.1, C92.2, G1S1.1, G1S1.2, G1R1.1, G1R1.2, 
G2S2.1, G2S2.2, G2R1.1, G2R1.2, G2R2.1, G2R2.2, G3S1.1, 
G3S1.2, G3S2.1, G3S2.2, G3R1.1, G3R1.2, G3R2.1, G3R2.2, 
G4S1.1, G4S1.2, G4S2.1, G4S2.2, G4R1.1, G4R1.2, G4R2.1, 
G4R2.2, G5R1.1, G5R1.4, G5R2.1, G5R2.2, G5R3.1, G5R3.2, 
G5R4.1, G5R4.2, G6R1.1, G6R1.3, G6R2.1, G6R2.2, G6R3.1, 
G6R3.2, G6R3.3, G6S1.1, G6S2.2, G6S3.1, G6S3.2, G7R1.2, 
G7R1.3, G7S1.1, G7S1.2, G7S2.1, G7S2.2, G7S3.1, G7S3.2, 
SO1.1, A11.1, A11.2, A12.1, A13.1, A13.2, A61.1, A62.1, A63.1, 
A71.1, A71.2, A71.4, A72.1 
6 
G7R1.1, G7R2.1, G7R2.2, SO1.1/6, A12.3, A21.1, A21.2, A22.1, 
A22.2, A63.2, A72.3, A73.1, A73.2, A73.3 
7 C83.3, C91.1, C91.3, A62.2 




Each clone isolated from our soil communities was categorised based on the 641 
morphologies found in Figure S2. Here we indicate which morphology each of 642 
our clones displayed. 643 
  644 
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Table S3: Soil community mortality rates 645 
Sample name  GO BO SO PO P1 P2 P3 P4 P5 P6 
Galleria  
mortality / 10 
9 1 7 9 9 3 7 2 9 4 
           
Sample name  C1 C2 C3 C4 C5 C6 C7 C8 C9 G1R 
Galleria  
mortality / 10 
10 5 6 1 10 3 9 7 8 10 
           
Sample name  G2R G3R G4R G5R G6R G7R G1S G2S G3S G4S 
Galleria  
mortality / 10 
10 10 10 8 10 10 10 9 7 9 
           
Sample name  G5S G6S G7S A1 A2 A3 A4 A5 A6 A7 
Galleria  
mortality / 10 
3 10 8 10 8 2 5 1 10 9 
Mortality of ten Galleria following injection with 10μl of the microbial community 646 
extracted from each soil sample and incubation at 37°C for 24hrs.  647 
P a g e  79 
P a g e  79 

























1 5 3  
G3R 
1 2 2 
2 4 2  2 2 2 
3 2 2  
G4S 
1 2 2 
4 1 1  2 2 2 
P5 
1 3 3  
G4R 
1 2 2 
2 1 1  2 2 2 
3 1 1  
G5R 
1 4 4 
4 3 2  2 2 2 
GO 1 4 0  3 2 2 
SO 1 2 2  4 2 2 
C1 
1 2 2  
G6R 
1 3 1 
2 2 2  2 2 1 
3 2 2  3 4 2 
C3 
1 2 2  
G6S 
1 2 1 
2 2 2  2 4 3 
C5 
1 2 2  3 2 1 
2 2 0  
G7R 
1 3 2 
3 2 0  2 2 2 
C7 
1 2 0  
G7S 
1 2 2 
2 3 2  2 2 2 
C8 
1 2 1  3 2 2 
2 2 1  
A1 
1 2 2 
3 3 1  2 3 2 
C9 
1 3 1  3 2 2 
2 2 0  
A2 
1 2 2 
G1S 1 2 2  2 2 2 
G1R 1 2 2  
A6 
1 2 2 
G2S 
1 2 2  2 2 1 
2 2 2  3 2 2 
G2R 
1 2 2  
A7 
1 4 2 
2 2 2  2 3 2 
G3S 
1 3 3  3 3 3 
2 2 2  
The exact number of clones isolated from each site and hemocoel extraction. 649 
Where possible we performed multiple hemocoel extractions for each sampling 650 
site to detect as many pathogens as possible. Similarly, we aimed to isolate at 651 
least one of every morphology found in each hemocoel extraction. Also indicated 652 
is the number of clones from each site and extraction which were later found to 653 
cause >50% Galleria mortality following injection of 105 CFU of each clone, and 654 
incubation at 37°C for 12hrs.655 
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 656 
Figure S3: Proportional number of clones isolated from each sampling site. Clones were isolated from Galleria hemocoel from each 657 
soil community that caused >50% Galleria mortality (Figure 3). Indicated in red are the proportion of clones found to cause >50% Galleria 658 
mortality following injection of 105 CFU of each clone, and incubation at 37°C for 12hrs. Those in blue caused ≤50% mortality. This data is 659 
further represented in Figure 7 and Table S4. 660 
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Trimmed 16s sequence used 
A12.2 Too short AGCGGCGGACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAG
ACTGGGATAACTCCGGGAAACCGGGGCTAATAC-
CGGATGCTTGATTGAACCGCATGGTTCA 


























These sequences were not accepted to the NCBI GenBank for the reasons 662 
described above. All other 16s sequences used were accessioned, their 663 
accession numbers can be found in Table 5.  664 
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Figure S4: Agarose gel electrophoresis images 665 
Agarose gels used to check the successful amplification of 16s and pfs gene 666 
targets following PCR. Reagents, amplification cycles and gel electrophoresis 667 
protocol are as stated in the methods section unless otherwise indicated.  668 
 669 
Checking for amplification of 16s DNA following PCR (20/11/2018). Sequences 670 
are from the following clones:  671 
Reference no. 1 2 3 4 5 6 7 8 
Source clone P11.1 P11.2 P12.1 P12.2 P13.1 P13.2 P14.1 P51.1 
         
Reference no. 9 10 11 12 13 14 15 16 
Source clone P51.2 P53.1 P54.1 C11.2 C12.2 C13.1 C31.1 C31.2 
         
Reference no. 17 18 19 20 21 22 23 24 
Source clone C32.1 C51.1 P54.2 C72.1 C72.3 C81.1 C81.2 C82.1 
         
Reference no. 25 26 27 28 29 30 31 32 
Source clone C83.1 C83.2 C91.2 C91.3 G1R1.1 G1S1.2 G2R1.2 G2S1.1 
         
Reference no. 33 34 35 36 37 38 39 40 
Source clone G2S2.2 G3R1.1 G3S1.1 G3S1.3 G4R1.1 G4S1.1 G5R1.1 G5R3.2 
         
Reference no. 41 42 43 44 45 46 
Source clone G5R4.2 G7R1.1 G7R2.2 G7S1.2 E. coli C- 
 672 
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 673 
Checking for amplification of 16s DNA following PCR (23/12/2018). Sequences 674 
are from the following clones:  675 
Reference no. 45 46 47 48 49 50 51 
Source clone P52.1 C13.2 C82.2 G5R1.2 G5R1.3 G5R2.1 G6R1.2 
        
Reference no. 52 53 54 55 56 57 58 
Source clone G6R3.4 G6S2.1 A83 G7R1.3 SO1.1/6 A11.2 A12.3 
        
Reference no. 59 60 61 62 63 64 20 
Source clone A21.2 A61.2 A63.2 A71.4 A72.3 A73.3 C72.1 
 
 
       
Reference no. 40 2 25 27 33 31 38 
Source clone G5R3.2 P11.2 C83.1 C91.2 G2S2.2 G2R1.2 G4S1.1 
        
Reference no. 65 66      
Source clone C+ C-      
 676 
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 677 
Checking for amplification of Serratia DNA following PCR using Serratia-specific 678 
pfs primer (12/3/2019). Sequences are from the following clones:  679 
Reference no. 1 2 3 4 5 6 7 
Source clone A61.2 C83.1 P11.1 P51.2 G4R1.2 A11.2 C12.2 
 
       
Reference no. 8 9 10 11 12 13 14 
Source clone C51.1 G1S1.2 G7R1.1 P12.1 C31.2 C91.3 Coli 
 
       
Reference no. 15 16 17 
    
Source clone P3 G3 - 
    
 680 
 681 
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Checking for amplification of Serratia DNA following PCR using Serratia-specific 682 
pfs primer (26/3/2019). Sequences are from the following clones:  683 
Reference no. 1 2 3 4 5 6 7 8 




Checking for amplification of Serratia DNA following PCR using Serratia-specific 687 
pfs primer (27/3/2019). Sequences are from the following clones:  688 
Reference no. 1 2 3 4 5 6 7 
Source clone C72.1 C81.2 C82.1 C83.2 C92.1 C92.2 G6R1.1 
        
Reference no. 8 9 10 11 12 13 14 
Source clone G6R1.3 G6R2.1 G6R3.2 G6R3.3 G6S1.1 G6S2.4 G6S3.2 
        
Reference no. 15 16 17     
Source clone G7R1.2 C+ C-     
 689 
 690 
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Checking for amplification of Serratia DNA following PCR using Serratia-specific 691 
pfs primer (4/4/2019). Sequences are from the following clones:  692 
 Reference no. 1 2 3 4 5 6 7 
Source clone C52.1 C72.1 C92.1 G6R1.1 G6R3.3 G7R1.2 A11.2 
 
       
Reference no. 8 9 
     
Source clone C+  C-  
    
 693 
 694 
Checking 16sF+R primers (freshly diluted from stock) (17/4/2019). Sequences 695 
are from the following clones:  696 
Reference no. 1 2 3 4 5 
Source clone A12.2 A62.2 Colony C+ (C81.2) C- (H20) 
 697 
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698 
Checking remaining 16s extractions from 11-4 (18/4/2019). Sequences are from 699 
the following clones: 700 
Reference no. 1 2 3 4 5 6 7 
Source clone A71.2 A71.3 A72.2 C52.1 C71.1 C71.2 C91.1 
        
Reference no. 8 9 10 11 12 13 14 
Source clone C92.1 G6R1.1 G6R1.3 G6R2.1 G6R3.2 G6R3.3 G6S2.4 
 
       
Reference no. 15 16 17 18 19 20 21 
Source clone G6S3.2 P11.1 P11.2 P54.2 CS.1b* FL* C+ (C81.2) 
 
       
Reference no. 22 23      
Source clone C- (H20) C- (H20)      
*These clones being sequenced in aid of other experiments   701 
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